High Tide Inc (HITI)

High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026June 17, 2026 6:00 AM
PR Newswire (Canada) CALGARY, AB, June 17, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its majority-owned subsidiary, Remexian Pharma GmbH ("Remexian"), showcased its exclusive German medical cannabis distribution partnerships with leading Canadian cannabis brands at Mary Jane Berlin 2026, one of Europe's largest cannabis trade shows, held June 11–14, 2026, in Berlin, Germany. Through these partnerships, Remexian is bringing premium Canadian medical cannabis products to German patients and pharmacies, further strengthening its position as a leading importer and distributor in one of the world's fastest-growing medical cannabis markets. At the event, Remexian featured medical cannabis products from Tribal, Highly Dutch Organic, Weed Me, The Loud Plug, Joi Botanicals and Castle Rock Farms, highlighting its growing portfolio of exclusive brand distribution agreements and connecting these Canadian brands directly with pharmacies, healthcare professionals, patients and other key stakeholders across Germany's rapidly expanding medical cannabis ecosystem.Germany continues to represent one of the most significant growth opportunities in the global medical cannabis industry, and Remexian's participation in Mary Jane Berlin further reinforces its position as a trusted importer and distributor of premium Canadian medical cannabis products. The event also supported the continued expansion of Remexian's pharmacy network and strengthened relationships with healthcare professionals and industry participants throughout the country."The response we received at Mary Jane Berlin reinforces what we are seeing across the German market: patients and healthcare professionals are actively seeking differentiated, high-quality cannabis products backed by trusted brands. Through Remexian, we are bringing some of Canada's most recognized and in-demand cannabis brands directly to this growing patient base. We believe our unmatched procurement capabilities and expanding portfolio of exclusive distribution agreements are creating a meaningful competitive advantage in Germany," said Raj Grover, Founder and Chief Executive Officer of High Tide."By continuously broadening our product offering and strengthening relationships across the supply chain, we are positioning Remexian to capture an even larger share of one of the world's most attractive medical cannabis markets. This is another example of how High Tide is leveraging its Canadian strengths to build a globally diversified cannabis platform with multiple avenues for long-term growth," Added Mr. GroverABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 228 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the growth potential for Remexian and the ability to capture further market share. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tides-german-subsidiary-remexian-pharma-showcases-exclusive-canadian-medical-cannabis-brand-partnerships-at-mary-jane-berlin-2026-302802470.htmlSOURCE High Tide Inc. Original: High Tide's German Subsidiary Remexian Pharma Showcases Exclusive Canadian Medical Cannabis Brand Partnerships at Mary Jane Berlin 2026

HITI............................................p/m

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MMJune 15, 2026 4:00 PM
PR Newswire (Canada) The Company Also Reports Positive Free Cash Flow and Net IncomeThe Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive GrowthCanadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous YearELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis Retail Market Across the Five Provinces in Which the Company Has a Presence2CALGARY, AB, June 15, 2026 /CNW/ – High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today released its financial results for the second fiscal quarter of 2026 ended April 30, 2026, the highlights of which are included in this news release. The full set of unaudited condensed interim consolidated financial statements for the three months ended April 30, 2026 and 2025 (the "Financial Statements") and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.hightideinc.com, its profile pages on SEDAR+ at www.sedarplus.ca, and EDGAR at www.sec.gov/edgar."Our second quarter results highlight the strength of High Tide's diversified growth strategy and our ability to execute at a high level across multiple geographies. Through the continued integration of Remexian, we have expanded our supply chain capabilities, eliminated unnecessary intermediaries, and are procuring biomass at materially lower costs than Remexian could on its own, enabling us to achieve key operational and financial objectives approximately 90 days ahead of our internal expectations," said Raj Grover, Founder and Chief Executive Officer of High Tide."Meanwhile, our core Canadian bricks-and-mortar business continues to outperform the broader cannabis retail sector across virtually every meaningful metric. This has resulted in High Tide reporting significantly higher income from operations, sustained positive free cash flow, and net income. As we look ahead, although we are already the leaders in both Canada and Germany when it comes to market share, we believe we have significant runway ahead to keep posting gains. We remain highly optimistic about the strong momentum we are generating, and are now eyeing other markets in Europe to build upon our global ambitions. I believe High Tide remains exceptionally well positioned for long-term value creation. In particular, we are thrilled to have a tier one bank as our long-term credit partner to fuel our global expansion," added Mr. Grover.______________________________________1 Based on public company reporting 2 Based on publicly available store count data for February 2026 and March 2026 in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulatorsSecond Fiscal Quarter 2026 – Financial Highlights:Revenue was a record $179.3 million for the three months ended April 30, 2026 compared to $137.8 million during the same period last year, an increase of 30% compared to last year, representing the fastest growth rate in 11 quarters. Revenue was up 1% sequentially during the three months ended April 30, 2026. Despite the quarter being seasonally slowest and having three fewer days, this was the fourth consecutive quarter marking a new all-time high in revenue.Gross profit was a record $48.4 million for the three months ended April 30, 2026, up 36% compared to the previous year and up 9% sequentially.Gross margin was 27% for the three months ended April 30, 2026, which was up from 26% a year ago, and up 200 basis points compared to 25% sequentially. The second fiscal quarter of 2026 marked an eight-quarter high in consolidated gross margin. The margins in the Company's medical cannabis distribution segment were 27% in the second fiscal quarter, which was more than double the first fiscal quarter's level of 12%.Adjusted EBITDA was yet another record of $13.9 million in the three months ended April 30, 2026. This was up 73% compared to last year, marking the fastest growth rate in nine quarters, and up 21% sequentially despite there being three fewer days in the quarter.  The Company generated $1.5 million in free cash flow in the three months ended April 30, 2026. While this was below the $4.9 million generated in the previous year, and $2.9 million sequentially, this was mainly due to working capital investments to grow the business. Cash flows from operations before changes in non-cash working capital reached a seven-quarter high at $8.8 million in the second fiscal quarter of 2026. During the past four quarters, the Company has generated $13.4 million in free cash flow.    General and administration expenses represented 4.0% of revenue in the three months ended April 30, 2026, which improved from 4.2% during the previous year, and 4.1% sequentially, and was the lowest level in seven quarters.Salaries, wages, and benefits represented 11.9% of revenue in the three months ended April 30, 2026, which improved from 12.7% during the previous year, and compared to 11.8% sequentially.Income from operations was a record $6.1 million in the three months ended April 30, 2026. This was up 554% compared to last year, and up 157% sequentially. During the second fiscal quarter, the Company generated positive net income, which represented significant improvements from a net loss of $2.8 million compared to a year ago, and a net loss of $0.4 million sequentially. Adjusted for changes in non-cash derivative liability, which were driven by out performance in the Company's medical cannabis distribution segment ahead of management's expectations, and excluding the non-controlling interest, net income was $0.6 million, marking a meaningful reversal from $(2.9) million a year ago, and $(2.1) million sequentially.During the second fiscal quarter, adjusted for changes in non-cash derivative liability, earnings per fully diluted share were $0.01, which improved from $(0.04) a year ago and $(0.02) sequentially.Cash and cash equivalents, including restricted cash, as at April 30, 2026 totaled $36.5 million, which compared to $34.7 million in the prior year, and $46.4 million sequentially.Second Fiscal Quarter 2026 – Retail Highlights:Canadian Cabana Club membership has surpassed 2.65 million, an increase of 39% compared to last year, and 3% sequentially. In the last twelve months, the Cabana Club added 750,00 new members. Cabana Club remains the largest cannabis loyalty program globally. The Company has also exceeded 178,000 ELITE members in Canada, an increase of 84% from the previous year and 10% sequentially.The average Canna Cabana store generated 1.9x revenue versus peers.3Same-store sales were (1.2%) compared to last year in the second fiscal quarter of 2026. Based on public filings and the intelligence the Company has gathered, it believes that it nevertheless outperformed its publicly traded and privately held peers. Since the launch of its discount club model in October 2021, same store sales at Canna Cabana are up 161% while the average operator has experienced a 7% decline in sales.4Canna Cabana maintained a 12% market share, consistent with the previous year.5 Excluding British Columbia, where all cannabis retailers are capped at eight stores, Canna Cabana's market share was 14%, up from 13% in the previous year.For the 12 months ended March 2026, total industry sales in the five provinces where the Company operates were up 3% year over year.  In contrast, total Canna Cabana sales were up 13% during this period. Canna Cabana had a shrink rate of 0.2% during the three months ended April 30, 2026.  This marked an improvement from 0.3% during each of the three months ended January 31, 2026, and April 30, 2025.Excluding stores open less than six months which are still ramping up, annualized retail sales per square foot were $1,620 across the Canna Cabana store network during the second fiscal quarter of 2026, which was 5% lower compared to the previous year and 6% sequentially, largely due to the three fewer days in the quarter. This was higher than many best-in-class international retailers.___________________________________3 For the month of March 2026, based on publicly available store count data in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulators4 Calculated by chaining monthly data, and based on publicly available store count data in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulators5 For the months of February 2026 and March 2026, based on publicly available store count data in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulatorsSecond Fiscal Quarter 2026 – Operational Highlights (February 1, 2025 – April 30, 2026): The Company opened three new Canna Cabana locations in Ontario—Scarborough, Sarnia and Caledonia—bringing the total Canna Cabana store count to 221 locations across Canada.The Company announced the appointment of Kathleen Skerrett and Menashe Kestenbaum as directors of the Company, and the appointment of David Wallach and Filip Ernest as members of the Company's Advisory Board.The Company's wholly owned U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, announced its intention to pursue participation in the U.S. Centers for Medicare & Medicaid Services Innovation Center's Beneficiary Engagement Incentive pilot program as a supplier of eligible hemp-derived CBD products, and began engaging with participating organizations.Subsequent Events (May 1, 2026 - Present): The Company opened new Canna Cabana locations in Toronto and Welland, and announced a new location in Calgary alongside a definitive agreement to acquire four stores in Ontario, which will bring the total Canna Cabana store count to 228 locations across Canada.The Company secured credit approval from Bank of Montreal for $40MM of credit facilities as its new senior lender.Certain officers, directors, and consultants, led by the Company's President and Chief Executive Officer, in the aggregate, acquired 90,882 common shares in the capital of High Tide on the open market between May 6, 2026, and May 8, 2026, at an average price of $3.39 per Common Share.Second Fiscal Quarter 2026 – Medical Cannabis Update During the second fiscal quarter of 2026, Remexian distributed a record 7.6 tonnes of medical cannabis into the German market, marking the highest quarterly distribution volume in the company's history. Volumes increased 49% compared to the previous year and 21% sequentially.The segment generated record revenue of $31.6 million during the second fiscal quarter of 2026, compared to $25.0 million during the first fiscal quarter of 2026.During the second fiscal quarter of 2026, Remexian generated gross margin of 27%, more than doubling the 12% Remexian generated during the first fiscal quarter of 2026.Remexian's market share of tonnage distributed in Germany now exceeds 14% for the three months ended March 2026, building on its upward trajectory from 6.5% for the three months ended September 2025 and 10.3% for the three months ended December 2025.6___________________________________6 Market share estimate based on total BfArM import dataNote that Q4 2025 revenue and gross margin include two months of contribution from Remexian.Selected financial information for the Three Months Ended April 30, 2026:
(Expressed in thousands of Canadian Dollars)
Three months ended April 30,Six months ended April 30,
2026
2025
Change
2026
2025
Change
$
$
?
$
$
?Free cash flow(i)1,482
4,896
(70) %
4,421
2,996
48 %Net cash provided by operating activities 4,433
8,255
(46) %
10,293
8,938
15 %Revenue179,296
137,804
30 %
357,625
280,265
28 %Gross profit48,391
35,471
36 %
92,800
70,911
31 %Gross profit margin(ii)27 %
26 %
1 %
26 %
25 %
1 %Adjusted gross margin(iii)27 %
26 %
1 %
26 %
25 %
1 %Operating expense(iv)(35,267)
(27,409)
29 %
(68,909)
(55,760)
24 %Operating expense as a % of revenue(v)20 %
20 %
— %
19 %
20 %
(1) %Total expenses(42,294)
(34,539)
22 %
(84,332)
(69,912)
21 %Income from operations6,097
932
554 %
8,468
999
748 %Adjusted EBITDA(vi)13,916
8,062
73 %
25,373
15,151
67 %Adjusted EBITDA as a percentage of revenue(vii)8 %
6 %
2 %
7 %
5 %
2 %Net income (loss)24
(2,836)
— %
(328)
(5,525)
— %Adjusted net income (loss) before fair value
change in derivative liability and excluding NCI(viii)565
(2,898)
— %
(1,516)
(5,706)
— %Adjusted basic and diluted income (loss) per share(ix)0.01
(0.04)
— %
(0.02)
(0.07)
— %i.Free cash flow is a non-IFRS financial measure prepared based on the calculation below.ii.Gross margin is  a non-IFRS financial measure. Gross margin is calculated by dividing gross profit by revenue.iii.Adjusted gross margin is a non-IFRS financial measure. Adjusted gross margin is calculated by dividing adjusted gross profit by revenue. Adjusted gross profit is calculated by excluding the inventory fair value from gross profit.iv.Operating expense is a non-IFRS measure and includes salaries, wages and benefits, general & administration, professional fees, advertising & promotion, and interest & bank charges.v.Operating expense as a % of revenue is a non-IFRS financial measure. This metric is calculated as operating expense divided by revenue.vi.Adjusted EBITDA is a non-IFRS financial measure. A reconciliation of the Adjusted EBITDA to Net income (loss) is found below.vii.Adjusted EBITDA as a percentage of revenue is a non-IFRS financial measure. This metric is calculated as adjusted EBITDA divided by revenue.viii.Adjusted net (loss) income before fair value change in derivative liability is a non-IFRS financial measure which is calculated by subtracting fair value change in derivative liability from net loss.ix.Adjusted basic and diluted income (loss) per share is a non-IFRS financial measure and calculated as adjusted net income (loss) before fair value change in derivative liability divided by weighted average number of common shares.The reconciling items between net earnings, EBITDA, and Adjusted EBITDA are as follows:
202620252024
Q2Q1Q4Q3Q2Q1Q4Q3Net (loss) Income24(352)(46,711)832(2,836)(2,689)(4,802)825Income/deferred tax recovery (expense)29540(178)694638(153)671Accretion and interest3,1513,1551,2131,7951,9502,1012,3081,681Depreciation and amortization6,1468,0266,5036,0805,8805,8475,3625,678EBITDA(i)9,61610,869(39,173)8,7765,0405,2972,7158,855Inventory fair value792690865—————Foreign exchange (gain) loss(212)(144)333120114(13)519Transaction and acquisition costs2,0772,9582,6828811,61663077312Other (gain) loss——(41)(1)42—(874)6Impairment loss——23,564———4,964—Share-based compensation 8813706688241,2501,175750881Loss (gain) on fair value change in derivative liability762(3,286)23,51643——(88)(159)Adjusted EBITDA(i)13,91611,45712,41410,6438,0627,0898,2459,614Adjusted EBITDA margin(ii)8 %6 %8 %7 %6 %5 %6 %7 %Adjusted EBITDA - trailing twelve months48,43042,57638,20834,03933,01034,98938,33538,452i.EBITDA and Adjusted EBITDA are non-IFRS financial measures.ii.Adjusted EBITDA margin is a non-IFRS financial measure. This metric is calculated as Adjusted EBITDA divided by revenue. 
202620252024
Q2Q1Q4 Q3 Q2 Q1 Q4 Q3Cash flow from operating activities 8,7525,4866,5998,2314,6864,6446,1798,928Changes in non-cash working capital(4,319)374(2,321)2,4193,569(3,961)3,473(2,715)Net cash provided by operating activities 4,4335,8604,27810,6508,2556839,6526,213Sustaining capex(i)(289)(286)(345)(460)(692)(361)(533)(279)Lease liability payments(2,662)(2,635)(2,610)(2,508)(2,667)(2,222)(3,211)(2,842)Free cash flow(ii)1,4822,9391,3237,6824,896(1,900)5,9083,092Free cash flow - trailing twelve months13,42616,84012,00116,58611,99616,48321,99121,770i.Sustaining capex is a non-IFRS measure.ii.Free cash flow is a non-IFRS measure.OUTLOOK Bricks-and-Mortar Retail High Tide's wholly owned subsidiary, Canna Cabana, is the largest cannabis retail chain in Canada with 228 locations, subject to the closing of the Company's announced acquisition of four new stores. As previously communicated, the Company reiterates  its long-term goal of surpassing 350 locations nationwide and opening 20-30 locations in calendar 2026, mostly through organic growth, while also evaluating supplemental M&A opportunities of varying sizes.White Label InitiativesThe Company continues to expand its white label cannabis product portfolio under its flagship Queen of Bud and Cabana Cannabis Co. brands, reaching 41 SKUs across the Canna Cabana store network as at the end of the second fiscal quarter. The Company is also developing several new offerings to further grow its white label portfolio. Currently, white label cannabis SKUs represent approximately 1.7% of the Company's total bricks-and-mortar cannabis sales. Over the long term, the Company anticipates significant growth in its white label portfolio and expects sales of its higher-margin white label brands to reach approximately 20% of total sales.Cabana Club & ELITEThe Company's Cabana Club and ELITE loyalty programs, which remain the largest such cannabis loyalty programs in the world, continue to expand at a rapid pace across Canada. Cabana Club membership has now surpassed 2.65 million members in Canada, which is up 39% in the past year. Over the long term the Company anticipates exceeding 3 million Cabana Club members in Canada. ELITE, the paid membership tier now exceeds 178,000 members in Canada—after growing by 84% compared to last year—with additional members being onboarded daily. The Company's long term goal is to convert at least 50% of its base tier members into ELITE.EuropeRemexian continued to gain share of the German medical cannabis market during the second fiscal quarter of 2026, reaching 14% for the three months ended March 2026, up from 10.3% for the three months ended December 2025. Management is encouraged by this trajectory and believes the Company is well positioned to sustain, and potentially grow, its share of the German medical cannabis market in the quarters ahead, supported by its unmatched Canadian supply relationships and the continued growth in the medical cannabis sector in Germany. Consistent with its previously communicated goals and timelines, the Company intends to expand into additional European markets over the coming quarters.United StatesThe Company's conviction in the long-term opportunity for its U.S. hemp-derived CBD platforms continues to be reinforced by an evolving federal policy environment. Consistent with the rationale behind becoming founding members of the U.S. National Compassionate Care Council, the Company and NuLeaf Naturals remain focused on helping to shape thoughtful federal and state medical cannabis policy while supporting efforts to expand patient access to cannabinoid therapies.Federal reform in the U.S. has continued to accelerate. On April 23, 2026, the U.S. Department of Justice and Drug Enforcement Administration moved FDA-approved marijuana drug products and marijuana subject to a state medical marijuana license from Schedule I to Schedule III of the Controlled Substances Act, the most significant shift in U.S. federal cannabis regulation in decades. Building on that order, the DEA has scheduled a new administrative hearing to begin on June 29, 2026 to consider whether all cannabis should be moved from Schedule I to Schedule III. The Company intends to monitor this proceeding closely and has already begun outreach to the Nasdaq Stock Exchange and the TSX Venture Exchange to better understand the impact that broader rescheduling could have on their respective listing policies.The Company continues to engage with multiple counter parties in the U.S. to explore potential opportunities.ATM PROGRAM QUARTERLY UPDATEThe Company has not issued equity via an ATM Program for the last five fiscal quarters.During the six months ended April 30, 2025, the Company issued an aggregate of 11,600 Common Shares over the Nasdaq or TSXV, for aggregate gross proceeds of $52. Pursuant to the Equity Distribution Agreement cash commission of $1 on the aggregate gross proceeds raised was paid to the Agents in connection with their services under the Equity Distribution Agreement during year ended October 31, 2025. This ATM Program was effective until July 24, 2025, when the Canadian Shelf Prospectus was withdrawn in order to file a new base shelf prospectus on August 11, 2025.On August 11, 2025, the Company filed a final short form base shelf prospectus in all Canadian provinces and territories and a corresponding shelf registration statement with the U.S. Securities and Exchange Commission. The shelf prospectus allows the Company to issue up to $100,000 (or the equivalent in U.S. dollars) of Common Shares from the treasury to the public from time to time, at the Company's discretion and subject to regulatory requirements, as required pursuant to National Instrument 44-102 – Shelf Distributions and the policies of the TSXV.As at the date the financial statements were authorized for issue, no securities had been issued under the shelf and no at-the-market distribution agreement or prospectus supplement had been entered into.WEBCAST LINK FOR TIDE EARNINGS EVENT The Company will host a webcast and conference call to discuss its audited results and outlook at 11:30 AM (Eastern Time) on Tuesday, June 16, 2026.https://app.webinar.net/49ONKGgKpM6Participants are encouraged to pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above. Participants who wish to ask questions during the event may do so through the call-in line, the access information for which is as follows: North American Toll Free: 1-888-510-2154
International Toll Free (Germany): 498005889782ABOUT HIGH TIDE High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada with 228 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada. High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: The Company's business objectives and milestones and the anticipated timing of, and costs in connection with, the execution or achievement of such objectives and milestones (including, without limitation, proposed acquisitions, expansions and store openings); the Company's future growth prospects and intentions to pursue one or more viable business opportunities; the development of the Company's business and future activities following the date hereof; expectations relating to market size and anticipated growth in the jurisdictions within which the Company may from time to time operate or contemplate future operations; expectations with respect to economic, business, regulatory, or competitive factors related to the Company or the cannabis industry generally; the market for the Company's current and proposed product offerings, as well as the Company's ability to capture market share; the distribution methods expected to be used by the Company to deliver its product offerings; the Company's strategic investments and capital expenditures, and related benefits; changes in general and administrative expenses; future business operations and activities and the timing and performance thereof; the future tax liability of the Company; the estimated future contractual obligations of the Company; the future liquidity and financial capacity of the Company and its ability to fund its working capital requirements and forecasted capital expenditures; the competitive landscape within which the Company operates and the Company's market share or reach; the Company adding the number of additional cannabis retail store locations the Company proposes to add to the Company's business upon the timelines indicated herein; the Company remaining on a positive growth trajectory; same-store sales continuing to increase; the Company making increases to its revenue profile; the Company completing the development of its cannabis retail stores; the Company's ability to generate positive free cash flow and remain free cash flow positive for the fiscal year; free cash flow allowing the Company to finance its growth with internal cash flows; the Company's ability to maximize shareholder value; the Company's ability to obtain, maintain, and renew or extend, applicable authorizations, including the timing and impact of the receipt thereof; the realization of cost savings, synergies or benefits from the Company's recent and proposed acquisitions; the Company's ability to successfully integrate the operations of any business acquired within the Company's business; the anticipated sales from continuing operations; the ability of the company to use cash generated from existing operations to fund future locations; Cabana Club and ELITE loyalty programs membership continuing to increase; the anticipated changes to and effects of the ELITE program on the business and operations of the Company; the Company hitting its forecasted revenue and sales projections; the intention of the Company to complete any offering of securities of the Company; the aggregate amount of the total proceeds that the Company will receive pursuant to any future offering; the Company's expected use of the net proceeds from the ATM Program and/or any future offering; the listing of Common Shares offered in any future offering; the anticipated effects of any future offering on the business and operations of the Company; the Company's ability to enter emerging legal cannabis jurisdictions, the ability of the Company to capture additional market share in the amount and on the timelines indicated herein; the ability of the Company to add 20-30 stores this calendar year and reach its goals of 350 stores nationwide, 1 million ELITE members, and 3 million Cabana Club members in Canada, and to convert 50% of base tier members to ELITE, the ability of the Company to sustain or grow its share of the German medical cannabis market and to expand into further European markets in coming quarters; whether additional working capital will be needed to grow Remexian; the ability to remain free cash flow positive for the 2026 fiscal year; the closing of announced acquisitions, the ability of the Company to develop and launch cannabis, white label, and consumption accessory offerings and for sales of its higher-margin white label brands to grow to 20%; the continued stabilization and improvement of e-commerce platforms, the ability to fund store growth internally; and the ability of the Company and its subsidiaries to capitalize on further federal reforms in the U.S. and elsewhere and for these to be a growth opportunity for the Company.Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. CAUTIONARY NOTE REGARDING FUTURE ORIENTED FINANCIAL INFORMATION  This press release may contain future oriented financial information ("FOFI") within the meaning of applicable securities legislation about prospective results of operations, financial position or cash flows, which is subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above "Cautionary Note Regarding Forward-Looking Statements". FOFI is not presented in the format of a historical balance sheet, income statement or cash flow statement. FOFI does not purport to present the Company's financial condition in accordance with IFRS as issued by the International Accounting Standards Board, and there can be no assurance that the assumptions made in preparing the FOFI will prove accurate. The actual results of operations of the Company and the resulting financial results will likely vary from the amounts set forth in the analysis presented, and such variation may be material (including due to the occurrence of unforeseen events occurring subsequent to the preparation of the FOFI). The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments as of the applicable date. However, because this information is highly subjective and subject to numerous risks, readers are cautioned not to place undue reliance on the FOFI as necessarily indicative of future results. Except as required by applicable securities laws, the Company undertakes no obligation to update such FOFI. Importantly, the FOFI contained in this press release are, or may be, based upon certain additional assumptions that management believes to be reasonable based on the information currently available to management, including, but not limited to, assumptions about: (i) the future pricing for the Company's products, (ii) the future market demand and trends within the jurisdictions in which the Company may from time to time conduct the Company's business, (iii) the Company's ongoing inventory levels, and operating cost estimates, and (iv) the Company's net proceeds from the ATM Program and future financings. The FOFI or financial outlook contained in this press release do not purport to present the Company's financial condition in accordance with IFRS as issued by the International Accounting Standards Board, and there can be no assurance that the assumptions made in preparing the FOFI will prove accurate. The actual results of operations of the Company and the resulting financial results will likely vary from the amounts set forth in the analysis presented in any such document, and such variation may be material (including due to the occurrence of unforeseen events occurring subsequent to the preparation of the FOFI). The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments as at the applicable date. However, because this information is highly subjective and subject to numerous risks including the risks discussed under the heading above entitled "Cautionary Note Regarding Forward-Looking Statements" and under the heading "Risk Factors" in the Company's public disclosures, FOFI or financial outlook within this press release should not be relied on as necessarily indicative of future results. Readers are cautioned not to place undue reliance on the FOFI, or financial outlook contained in this press release. Except as required by Canadian securities laws, the Company does not intend, and does not assume any obligation, to update such FOFI. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-reports-second-quarter-2026-financial-results-featuring-record-revenue-of-179-3mm-and-adjusted-ebitda-of-13-9mm-302800698.htmlSOURCE High Tide Inc. Original: High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

High Tide Reports Second Quarter 2026 Financial Results Featuring Record Revenue of $179.3MM, and Adjusted EBITDA of $13.9MM

June 15, 2026

• The Company Also Reports Positive Free Cash Flow and Net Income

• The Company's German Medical Cannabis Subsidiary, Remexian Pharma GmbH (Remexian) Generated Record Revenue of $31.6 Million with Gross Margins Increasing to 27%

• The Company Has Secured Credit Approval with Bank of Montreal for $40MM of Senior Secured Credit Facilities to Fuel Further Non-Dilutive Growth

• Canadian Cabana Club Membership Now Exceeds 2.65 Million, Up 39% Compared to the Previous Year

• ELITE Members in Canada Have Surpassed 178,000, Up 84% Compared to the Previous Year

• High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis Retail Market Across the Five Provinces in Which the Company Has a Presence 2

CALGARY, AB, June 15, 2026 /PRNewswire/ – High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today released its financial results for the second fiscal quarter of 2026 ended April 30, 2026, the highlights of which are included in this news release. The full set of unaudited condensed interim consolidated financial statements for the three months ended April 30, 2026 and 2025 (the "Financial Statements") and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.hightideinc.com, its profile pages on SEDAR+ at www.sedarplus.ca, and EDGAR at www.sec.gov/edgar.

"Our second quarter results highlight the strength of High Tide's diversified growth strategy and our ability to execute at a high level across multiple geographies. Through the continued integration of Remexian, we have expanded our supply chain capabilities, eliminated unnecessary intermediaries, and are procuring biomass at materially lower costs than Remexian could on its own, enabling us to achieve key operational and financial objectives approximately 90 days ahead of our internal expectations," said Raj Grover, Founder and Chief Executive Officer of High Tide."Meanwhile, our core Canadian bricks-and-mortar business continues to outperform the broader cannabis retail sector across virtually every meaningful metric. This has resulted in High Tide reporting significantly higher income from operations, sustained positive free cash flow, and net income. As we look ahead, although we are already the leaders in both Canada and Germany when it comes to market share, we believe we have significant runway ahead to keep posting gains. We remain highly optimistic about the strong momentum we are generating, and are now eyeing other markets in Europe to build upon our global ambitions. I believe High Tide remains exceptionally well positioned for long-term value creation. In particular, we are thrilled to have a tier one bank as our long-term credit partner to fuel our global expansion," added Mr. Grover.

1 Based on public company reporting

2 Based on publicly available store count data for February 2026 and March 2026 in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulators

https://www.nasdaq.com/press-release/high-tide-reports-second-quarter-2026-financial-results-featuring-record-revenue

$HITI 🗞️

High Tide Secures Credit Approval for C$40MM of Senior Secured Credit FacilitiesJune 15, 2026 6:15 AM
PR Newswire (US) CALGARY, AB, June 15, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that, further to its press release dated May 5, 2026, it has secured credit approval for a loan agreement (the "Loan Agreement") with Bank of Montreal ("BMO") in respect of new senior secured credit facilities in the principal amount of C$40 million (the "New Credit Facilities"). Closing of the New Credit Facilities remains subject to the satisfaction of customary closing conditions. Upon closing, the New Credit Facilities will replace the Company's existing senior credit facility. "This is a defining moment for High Tide and speaks volumes about the scale, consistency, and quality of what we have built. Our new senior lender's facility translates directly into materially lower-cost capital as we enter our next phase of growth," said Raj Grover, Founder and Chief Executive Officer of High Tide.TRANSACTION DETAILSThe Loan Agreement provides for two committed facilities, on terms consistent with those announced by the Company on May 5, 2026:A $25 million committed revolving facility with a three-year maturity, to be used to refinance the Company's loan with connectFirst at closing, for general working capital and corporate requirements, and for permitted acquisitions and permitted investments. The balance owing to connectFirst is expected to be slightly over $6 million at closing, resulting in almost $19 million of available room on the revolving facility.A $15 million committed delayed draw term loan to be used to refinance the Company's existing $15 million second-lien debentures.Funds under the New Credit Facilities will become available to the Company, following the satisfaction of customary closing conditions, at which time the Company's existing senior credit facility will be repaid. The Company will provide a further update upon closing expected within approximately 30 days.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 228 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the closing of the New Credit Facilities and the satisfaction of customary closing conditions; the timing of closing; the repayment of the Company's existing senior credit facility; the use of proceeds from the New Credit Facilities being utilized as outlined herein; the expected balance owing to its existing senior lender at closing and the resulting availability under the revolving facility; the ability of the Company to comply with the financial covenants; the anticipated effects of the New Credit Facilities on the business and operations of High Tide; and the ability of the Company to pursue accretive growth across its retail network, scale its German platform through Remexian, and expand into other federally legal markets. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-secures-credit-approval-for-c40mm-of-senior-secured-credit-facilities-302799870.htmlSOURCE High Tide Inc. Original: High Tide Secures Credit Approval for C$40MM of Senior Secured Credit Facilities

High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in OntarioJune 15, 2026 6:00 AM
PR Newswire (Canada) CALGARY, AB, June 15, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is taking yet another step to expand its bricks-and-mortar retail cannabis operations, by entering into a definitive agreement (the "Acquisition Agreement") pursuant to which High Tide will acquire 100% of the equity interest of J. Supply Holdings Inc., operating as Northern Helm ("Northern Helm"), resulting in High Tide's acquisition of four of the six retail cannabis stores currently operated by Northern Helm in Ontario (the "Stores") for $7.74 Million (the "Transaction"). The Stores are located at 2377 Highway 2 in Bowmanville, 225 Gore Road in Kingston, 1414 King St. E in Courtice, and 199 Wentworth St W in Oshawa. These acquisitions will bring High Tide's total store count to 228 Canna Cabana locations across Canada and 103 in the province of Ontario. "This acquisition highlights exactly how we intend to continue creating shareholder value: acquiring strong cash-flowing assets at reasonable multiples, integrating them into our proven operating platform, and compounding earnings over time. Surpassing 100 stores in Ontario will be a significant achievement, but we view it as another step toward our long-term objective of building a 350-plus store network that remains unmatched in scale, efficiency, and customer loyalty," said Raj Grover, Founder and Chief Executive Officer of High Tide."At the same time, the success of our medical cannabis division demonstrates that High Tide is evolving into much more than a retail company. As our retail business continues to outperform and gain market share, our medical cannabis platform is rapidly emerging as a second engine of growth. With strong momentum across both segments, multiple avenues for expansion, and a proven ability to execute, I believe we are exceptionally well-positioned to continue widening our competitive moat, compounding shareholder value, and delivering sustainable growth for years to come. I look forward to sharing our progress with the release of financial and operational results for the second fiscal quarter at the close of markets today," added Mr. Grover.Transaction DetailsThe Transaction, which is an arm's length transaction, is subject to, among other things, receipt of the required approvals from the TSX Venture Exchange ("TSXV") and the Alcohol and Gaming Commission of Ontario ("AGCO"), and the satisfaction of other customary conditions of closing, and is expected to close in the coming weeks. The consideration (the "Consideration") for the 100% of equity interests acquired will be approximately $3.2M in assumed debt with a 2% interest rate, with 40% of the remaining amount paid in cash, (approximately $1.83M), and the remaining 60% (approximately $2.75M) paid in common shares of High Tide ("High Tide Shares") on closing (the "Closing") on the basis of a deemed price per High Tide Share equal to the 10-day volume weighted average price of the High Tide Shares on the TSXV ending on the trading day that is three business days prior to the Closing date, subject to a floor price equal to the Discounted Market Price (as defined by the TSXV) as of the day prior to this news release. The High Tide Shares will be subject to a statutory and contractual hold period of four months and one day from the date of Closing. The purchase price represents 4.5x the annualized Adjusted EBITDA of the Stores for the three months ended March 31, 2026.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 228 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements are often, but not always, identified by words such as "expect", "intend", "plan", "believe", "anticipate", "estimate", "may", "will", "could", "should" and similar expressions. Forward-looking statements in this news release include, without limitation, statements relating to: the expected final purchase price of the Transaction; whether all approvals will be received and conditions precedent will be satisfied; whether the Transaction will close on the timeline indicated herein.Forward-looking statements are based on management's current expectations and assumptions as of the date of this news release, including assumptions regarding: the receipt of all required consents, regulatory approvals, authorizations, and satisfaction of customary conditions for the closing of the Transaction; the final purchase price for the Transaction after adjustments; he accuracy and continued applicability of third-party and internal market, demographic and competitive data relied upon by management; the ability of the Company to surpass its goal of 350 stores; the ability of the Company to continue delivering growth and shareholder value; and the Company's ability to execute its retail expansion plans and operate the new stores as anticipated.Forward-looking statements are subject to risks, uncertainties and other factors that may cause actual results to differ materially, including, without limitation: delays or inability to obtain required regulatory approvals or authorizations; changes in competitive, market or consumer conditions; operational risks associated with opening and operating new stores; and the other risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-acquire-northern-helm-adding-four-established-retail-cannabis-stores-in-ontario-302799861.htmlSOURCE High Tide Inc. Original: High Tide to Acquire Northern Helm, Adding Four Established Retail Cannabis Stores in Ontario

High Tide to Open Two New Canna Cabana Locations in Welland and CalgaryJune 10, 2026 11:00 AM
PR Newswire (Canada) CALGARY, AB, June 10, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it has opened a new Canna Cabana branded location in Welland, Ontario, and expects to open an additional location in Calgary, Alberta. These openings bring High Tide's total store count to 224 Canna Cabana locations across Canada, 99 in the province of Ontario and 92 in the province of Alberta. "Our growth story continues to be driven by a simple formula: securing strategic real estate in high-potential markets and connecting more consumers to the value offered through our Cabana Club and ELITE programs. The addition of these locations further strengthens our network effect and expands our ability to acquire and retain loyal members across Canada," said Raj Grover, Founder and Chief Executive Officer of High Tide."We are especially pleased to reinforce our leadership position in Alberta, where High Tide was founded, while continuing to grow our presence in Ontario. As our store network and membership ecosystem expand together, we believe we are creating a competitive moat that becomes stronger with every new location we open," added Mr. Grover.WELLAND LOCATIONThe Company's new Canna Cabana located at 960 Niagara Street in Welland, Ontario will begin selling recreational cannabis products and consumption accessories for adult use on June 10, 2026. Marking the Company's first store in the city of Welland, the location anchors a newly developed commercial node at the north end of the city alongside a major grocer and other popular retailers. It serves a growing trade area of more than 65,000 residents within five kilometers, and limited existing competition, positioning it as the most convenient cannabis retail option for residents in the north end of Welland.CALGARY LOCATIONThe Company's new Canna Cabana located at 16 MacEwan Drive NW in Calgary, Alberta is expected to begin selling recreational cannabis products and consumption accessories for adult use on June 26, 2026, pending regulatory approval. The store anchors a new retail node in northwest Calgary, with no direct cannabis competition in its immediate trade area and only limited competition across a densely populated surrounding area of more than 60,000 residents within three kilometers. Situated alongside frequently visited retail locations, including a gas station and convenience store with ample parking, the location is an easily accessible neighbourhood stop. With the absence of any major competitor in the area, the site is strongly suited to the Company's value-driven discount club model.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 224 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the receipt of regulatory approvals for the store openings; the timing of the new locations opening and beginning to sell recreational cannabis products and consumption accessories for adult use; the expected benefits of the store locations; and the level of competition in the areas.Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-open-two-new-canna-cabana-locations-in-welland-and-calgary-302796835.htmlSOURCE High Tide Inc. Original: High Tide to Open Two New Canna Cabana Locations in Welland and Calgary

High Tide to Announce Second Fiscal Quarter 2026 Financial ResultsJune 3, 2026 6:00 AM
PR Newswire (US) CALGARY, AB, June 3, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it will release its financial and operational results for the quarter ended April 30, 2026, after financial markets close on Monday, June 15, 2026. High Tide's second fiscal quarter 2026 financial and operational results will be available on SEDAR+, EDGAR, and on the Company's website at https://hightideinc.com/invest.  Following the release of its second fiscal quarter financial and operational results, High Tide will host a webcast with Raj Grover, Founder and Chief Executive Officer, and Mayank Mahajan, Chief Financial Officer, to discuss the Company's financial results and what the remaining fiscal year holds for High Tide, at 11:30 AM Eastern Time on Tuesday, June 16, 2026.Webcast Link for High Tide Earnings Eventhttps://app.webinar.net/49ONKGgKpM6 Participants are encouraged to pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above.Participants who wish to ask questions during the event may do so through the call-in line, the access information for which is as follows: North American Toll Free: 1-888-510-2154
International Toll Free (Germany): 498005889782Employee Stock Options GrantIn addition, High Tide announces the grant of 66,500 incentive stock options (the "Options") to various employees of the Company. Each Option is exercisable at the closing price of the Company's common shares listed on the TSX Venture Exchange (the "TSXV") based on the last trading day immediately prior to this press release, expires three years from the date of grant, and vests over a two-year period. Each Option is exercisable to purchase one common share of the Company and are being issued pursuant to the terms of the Company's Omnibus Plan, which became effective on June 2, 2022.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 222 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada. High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan 
Chief Communications and Public Affairs Officer 
High Tide Inc. 
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the Company releasing its financial results on the timelines indicated herein. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-announce-second-fiscal-quarter-2026-financial-results-302789321.htmlSOURCE High Tide Inc. Original: High Tide to Announce Second Fiscal Quarter 2026 Financial Results

High Tide to Open New Canna Cabana in Toronto, OntarioMay 15, 2026 6:00 AM
PR Newswire (US) CALGARY, AB, May 15, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 150 Silver Reign Drive in Toronto, Ontario, is expected to begin selling recreational cannabis products and consumption accessories for adult use on May 17, 2026. This opening brings High Tide's total store count to 222 Canna Cabana locations across Canada and 98 in the province of Ontario. This new Canna Cabana location in Toronto's Rexdale neighbourhood is strategically positioned within an established power centre, anchored by leading big-box retailers and co-located alongside national specialty chains and quick-service restaurants. The opening marks Canna Cabana's first entry into this trade area, with no other Canna Cabana locations nearby. The site serves a dense and growing community of more than 263,000 residents within five kilometres, supported by strong household income demographics, and is well positioned to welcome adult-use cannabis consumers from across Etobicoke and northwest Toronto."This new Rexdale location further strengthens our presence in the Greater Toronto Area and expands Canna Cabana into a high-density retail corridor with attractive long-term demand characteristics. We believe our differentiated discount-club model continues to resonate with consumers seeking value, convenience, and a broader loyalty-driven retail experience," said Raj Grover, Founder and Chief Executive Officer of High Tide."As we approach 100 stores in Ontario and 222 stores nationally, we continue to focus on profitable and disciplined expansion that enhances our competitive advantages and deepens our connection with consumers. We believe our differentiated retail model and growing Cabana Club ecosystem position us to further consolidate market share in Canada's largest cannabis market," added Mr. Grover.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 222 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company, with a 14% share of the German medical cannabis market, built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Omar Khan
Chief Communications and Public Affairs Officer
High Tide Inc.
omar @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws (collectively, "forward-looking statements"). Forward-looking statements are often, but not always, identified by words such as "expect", "intend", "plan", "believe", "anticipate", "estimate", "may", "will", "could", "should" and similar expressions. Forward-looking statements in this news release include, without limitation, statements relating to: the expected timing of the opening of the new store and the commencement of sales at that location; the expected benefits of the store location and management's expectations regarding demand characteristics, customer traffic and competitive positioning in the surrounding trade area; and management's expectations regarding the Company's retail expansion strategy, including statements regarding further market share consolidation and the expected benefits of the Company's retail model and loyalty ecosystem.Forward-looking statements are based on management's current expectations and assumptions as of the date of this news release, including assumptions regarding: the receipt of any required regulatory approvals and authorizations for the store opening; the accuracy and continued applicability of third-party and internal market, demographic and competitive data relied upon by management; and the Company's ability to execute its retail expansion plans and operate the new store as anticipated.Forward-looking statements are subject to risks, uncertainties and other factors that may cause actual results to differ materially, including, without limitation: delays or inability to obtain required regulatory approvals or authorizations; changes in competitive, market or consumer conditions; operational risks associated with opening and operating new stores; and the other risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-open-new-canna-cabana-in-toronto-ontario-302773138.htmlSOURCE High Tide Inc. Original: High Tide to Open New Canna Cabana in Toronto, Ontario

High Tide Announces Purchases of Shares by InsidersMay 11, 2026 6:00 AM
PR Newswire (Canada) CALGARY, AB, May 11, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that certain officers, directors, and consultants, led by the Company's President and Chief Executive Officer (together, the "Insiders"), in the aggregate, acquired 90,882 common shares in the capital of High Tide ("Common Shares") on the open market between May 6, 2026, and May 8, 2026, at an average price of $3.39 per Common Share. The purchase of Common Shares by the Insiders reflects confidence in the intrinsic value of the stock and the near-term and long-term growth prospects of the Company. With these purchases, insiders and certain consultants, in the aggregate, now own or control 7,720,360 Common Shares, representing approximately 8.8% of the Company's issued and outstanding Common Shares as of today. "Over the last week, High Tide has continued to demonstrate why we believe we are one of the strongest operators in the global cannabis industry. We secured a new senior lending relationship with a Big 5 Canadian bank through a $40 million credit facility term sheet, reported record quarterly medical cannabis distribution volumes at Remexian, and completed a highly productive institutional investor roadshow across three cities. In addition, newly released BfArM Q1 2026 data indicates that Remexian's market share in Germany has risen to over 14%, more than doubling its share since our transaction, and further validating the strength of our international strategy," said Raj Grover, Founder and Chief Executive Officer of High Tide."I am very pleased to have increased my own ownership position alongside several members of our Board and leadership team following these developments. We believe the operational momentum across our retail platform, international business, and balance sheet continues to strengthen, and these insider purchases reflect our confidence in the long-term value we are building," added Mr. Grover.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 221 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the Company's near-term and long-term growth prospects and the expected benefits of its operational and international strategy; the anticipated effect of the recent insider purchases and the Company's expectations regarding future value creation; the expected completion, timing and terms of any credit facility or lending arrangement referenced in this news release (including any term sheet), and the expected benefits thereof; and management's expectations regarding the Company's operational momentum and future performance. Forward-looking statements are based on management's current expectations and assumptions as of the date of this news release, including assumptions regarding: the Company's ability to negotiate and execute definitive documentation for any financing or credit facility on acceptable terms and satisfy any conditions precedent; the accuracy and continued applicability of third-party and internal market data referenced in this news release; the Company's ability to execute its business plans; and general economic, market and regulatory conditions. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-purchases-of-shares-by-insiders-302767850.htmlSOURCE High Tide Inc. Original: High Tide Announces Purchases of Shares by Insiders

High Tide Reports Record Quarterly Distribution of 7.6 Tonnes of Medical Cannabis Through Remexian Pharma GmbH, Accelerating German Market LeadershipMay 6, 2026 6:00 AM
PR Newswire (US) CALGARY, AB, May 6, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today preliminary tonnage data from its 51%-owned German subsidiary, Remexian Pharma GmbH ("Remexian"), for the second fiscal quarter ended April 30, 2026.During the quarter, Remexian sold 7.6 tonnes of medical cannabis into the German market, representing the highest quarterly distribution volume in its history. Volumes increased 21% on a sequential basis and 49% year over year."Distributing 7.6 tonnes in a single quarter is not just a record for Remexian—it is clear evidence that our model is scaling in the largest medical cannabis market in Europe. What we are seeing now is the direct result of pairing a leading German distribution platform with High Tide's unparalleled procurement capabilities built over $2.2 billion of legal cannabis sales in Canada," said Raj Grover, Founder and Chief Executive Officer of High Tide."This level of sequential and year-over-year growth reinforces our conviction that Germany is only the beginning. We are building a repeatable, capital-efficient distribution engine that can be expanded across Europe, subject to regulatory conditions. We fully intend to leverage this momentum to continue taking share in Germany while methodically entering additional high-growth markets," added Mr. Grover.Germany imported 201.1 tonnes of medical cannabis in 2025, more than doubling the previous year's 72.9 tonnes, with almost half of its imports (over 93 tonnes) coming from Canada.1The foregoing Remexian tonnage figures are preliminary, unaudited and subject to revision upon completion of the Company's second fiscal quarter financial statements. They have not been reviewed or approved by the Company's audit committee or board of directors, and should not be relied upon as a substitute for the complete financial results that the Company expects to report in June 2026. Accordingly, these figures may differ from the amounts ultimately reported in the Company's interim financial statements and management's discussion and analysis for the quarter ended April 30, 2026. The Company will report its complete second fiscal quarter 2026 financial results, including revenue, gross profit, net income (loss) and adjusted EBITDA, in June 2026.___________________________
1 Source: Germany's Federal Institute for Drugs and Medical Devices (BfArM)ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 221 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices, with a market share exceeding 10% of tonnage imported. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the accuracy of the preliminary, unaudited tonnage figures and whether they will vary in the second fiscal quarter financial statements; the timing of the Company's release of its complete second fiscal quarter 2026 financial results; Remexian's ability to continue capturing share in the German medical cannabis market; the future growth of the German medical cannabis market; the Company's ability to leverage its Canadian procurement capabilities to expand Remexian's distribution; the Company's broader European expansion strategy and its ability to enter additional European medical cannabis markets; and the continued momentum of Remexian's operations. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-reports-record-quarterly-distribution-of-7-6-tonnes-of-medical-cannabis-through-remexian-pharma-gmbh-accelerating-german-market-leadership-302763671.htmlSOURCE High Tide Inc. Original: High Tide Reports Record Quarterly Distribution of 7.6 Tonnes of Medical Cannabis Through Remexian Pharma GmbH, Accelerating German Market Leadership

High Tide Executes a Term Sheet for $40MM of Credit Facilities with a Big 5 Canadian Chartered Bank As its New Senior LenderMay 5, 2026 6:00 AM
PR Newswire (US) CALGARY, AB, May 5, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that it has signed a term sheet (the "Term Sheet") with one of Canada's Big 5 chartered banks (the "Lender") in respect of new senior secured credit facilities (the "New Credit Facilities") in the principal amount of $40 million. Upon closing, the New Credit Facilities will replace the Company's existing senior credit facility with connectFirst Credit Union. The name of the Lender will be disclosed at closing, which is expected within 60 days subject to satisfaction of customary conditions precedent. "Having a Big 5 Canadian bank step in as our senior lender marks a clear inflection point for High Tide. This is not just access to capital — it is institutional validation of the scale, consistency, and quality of the business we've built. Our model is delivering where others have struggled, and that discipline is now translating into materially lower-cost capital," said Raj Grover, Founder and Chief Executive Officer of High Tide."In a capital-constrained industry, access to low-cost, scalable financing is a structural advantage — and one we intend to fully leverage. This facility strengthens our ability to pursue accretive growth across our retail network, scale our German platform through Remexian, and expand into other federally legal markets, all while maintaining the disciplined financial approach that continues to set High Tide apart," added Mr. Grover.Transaction DetailsThe Term Sheet is for two committed facilities:A $25 million committed revolver facility to be used to refinance the Company's loan with connectFirst at closing, general working capital / corporate requirements, permitted acquisitions and permitted investments.  The facility is to have a three-year maturity.  The balance at connectFirst is expected to be a little over $6 million at closing, resulting in almost $19 million of available room on the revolver facility.A $15 million committed delayed draw term loan to be used to refinance the Company's existing $15 million second-lien debentures.  The Company can elect to draw on this facility at its option, and it will be repaid over a seven-year amortization period.The applicable interest rate will depend on the Company's leverage in the future, but range between Prime + 2% and Prime + 3%.Financial covenants associated with The Facilities include maintaining: Senior Funded Debt / EBITDA 1.25x.  The Company has tested its internal model with these covenants and expects to be comfortably in compliance with all financial covenants.Signing the Term Sheet represented the conclusion of a multi-month process which included obtaining terms from multiple Tier 1 lenders. Beshay Soliman George (BSG) LLP assisted the Company during this process.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 221 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: that the New Credit Facilities will close on the terms and within the timelines set out in this press release, the use of proceeds from the New Credit Facilities being utilized as outlined herein, the ability of the Company to comply with the financial covenants, the anticipated effects of the New Credit Facilities on the business and operations of High Tide, and the ability of the Company to enter new markets. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-executes-a-term-sheet-for-40mm-of-credit-facilities-with-a-big-5-canadian-chartered-bank-as-its-new-senior-lender-302762099.htmlSOURCE High Tide Inc. Original: High Tide Executes a Term Sheet for $40MM of Credit Facilities with a Big 5 Canadian Chartered Bank As its New Senior Lender

High Tide Announces Proactive Steps to Investigate and Address Potential Manipulation of Its Common SharesApril 23, 2026 6:00 AM
PR Newswire (US)

CALGARY, AB, April 23, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today provides the following statement in connection with commentary that has recently appeared in various online forums and investor communities regarding the trading activity in the Company's common shares.







The Company wishes to address directly the concerns that have been raised, both publicly and through direct communications to management, regarding unusual trading patterns in High Tide common shares. The Company takes these concerns seriously. The board of directors and senior management have been actively monitoring and reviewing trading data in connection with the Company's common shares, including trading activity around the Company's earnings release dates.Over the course of more than the last ten consecutive quarters, the Company has delivered exceptional financial results almost always ahead of the expectations of analysts which cover its shares. Despite consistently positive after-hours market reactions to those results, the Company has observed a recurring pattern in which the closing price of its common shares on the following regular trading day has been lower than the prior day's closing price. The Company, together with its market maker, has been monitoring trading patterns, position reports, and related data in an effort to understand the source and nature of this activity.Based on the information gathered to date, the Company has reasonable grounds to believe that certain trading activity in its shares may not reflect normal market forces, and that certain conduct may be contrary to applicable securities laws in Canada and the United States. The Company intends to take decisive and proactive steps to fully investigate this matter.Steps Being TakenThe Company intends to retain qualified forensic investigators and industry specialists with experience in securities market structure and trading surveillance. These experts will conduct a thorough and independent review of the trading activity in High Tide common shares, with particular focus on activity surrounding the Company's earnings releases and other material disclosure events.The Company intends to provide the findings of that investigation, together with any supporting evidence, to the applicable regulatory authorities in Canada and the United States, including securities commissions and self-regulatory organizations with jurisdiction over trading conduct. The Company will cooperate fully with any regulatory inquiry that may arise from this matter.High Tide's management and board of directors are committed to protecting the interests of all shareholders and to ensuring that the market for the Company's common shares operates in a fair, transparent, and efficient manner consistent with the expectations of investors and the requirements of applicable law.Shareholder CommunicationThe Company encourages any shareholder or market participant who has information relevant to unusual trading activity in High Tide common shares to contact the Company at ir@hightideinc.com. All information received will be treated with appropriate confidentiality.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 221 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the ability of the Company to retain experts, the ability of the experts to conduct a thorough and independent review, and to provide the results of the investigation to securities regulators, the results of the investigation into the trading patterns of the Company's common shares and whether this conduct is contrary to applicable securities laws, and the ability of the Company to protect its shareholders interests. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-proactive-steps-to-investigate-and-address-potential-manipulation-of-its-common-shares-302751070.htmlSOURCE High Tide Inc.

Original: High Tide Announces Proactive Steps to Investigate and Address Potential Manipulation of Its Common Shares

High Tide Celebrates 4/20 with New Canna Cabana in Caledonia, OntarioApril 20, 2026 6:00 AM
PR Newswire (US)

CALGARY, AB, April 20, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 345 Argyle Street South in Caledonia, Ontario, will begin selling recreational cannabis products and consumption accessories for adult use on April 20, 2026. This opening brings High Tide's total store count to 221 Canna Cabana locations across Canada and 97 in the province of Ontario.







This new Canna Cabana location in Caledonia is strategically positioned at the south end of town, distinctly separated from the limited existing competition located on the north end, and anchors a high-draw commercial node that includes a pharmacy, liquor store, and multiple best-in-class national retailers. The site serves a growing trade area with strong household income demographics and is well placed to welcome adult-use cannabis consumers from across Caledonia and the surrounding Haldimand County region."Opening on 4/20 is always symbolic, but this year is especially meaningful as we approach eight years since launching our very first Canna Cabana store in October 2018. Since then, we've built one of the most original and recognized brands in cannabis by staying focused on delivering unbeatable value and a best-in-class experience for our Cabana Club members," said Raj Grover, Founder and Chief Executive Officer of High Tide."Bringing that experience to Caledonia on such a milestone day is something we're incredibly proud of. This location is another step forward as we continue to scale our model with discipline and deepen our connection with cannabis consumers across the country," added Mr. Grover.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 221 domestic and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the timing of the new locations opening and beginning to sell recreational cannabis products and consumption accessories for adult use; the expected benefits of the store locations; and the level of competition in the area. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-celebrates-420-with-new-canna-cabana-in-caledonia-ontario-302746855.htmlSOURCE High Tide Inc.

Original: High Tide Celebrates 4/20 with New Canna Cabana in Caledonia, Ontario

High Tide to Present at Several Major International Cannabis and Investor ConferencesApril 13, 2026 6:00 AM
PR Newswire (US)

CALGARY, AB, April 13, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that senior executives and advisors of the Company will speak on panels at several upcoming cannabis and investor conferences across North America and Europe.







CONFERENCE & PANEL SCHEDULETalman House
Berlin – April 13, 2026 – Raj Grover
A Shifting German Cannabis Landscape – 10:15 (GMT+2)International Cannabis Business Conference
Berlin – April 14, 2026 – Raj Grover
International Cannabis Investment Opportunities – 11:45 (GMT+2)Berlin – April 14, 2026 – Omar Khan
Cannabis Advocacy and Lobbying – 15:45 (GMT+2)D. Boral Capital Conference
New York – May 7, 2026 – Vahan AjamianCannabis Europa
London – May 26, 2026 – Raj Grover
Deal Flow & Due Diligence: Inside Europe's Next M&A Wave – 14:00 (GMT+1)
 TD Cowen Future of the Consumer Conference
New York – June 2, 2026 – Vahan Ajamian – 9:30 (EDT)
 Planet MicroCap
Las Vegas – June 17, 2026 – Raj Grover – 10:00 (EDT)ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 220 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-to-present-at-several-major-international-cannabis-and-investor-conferences-302740050.htmlSOURCE High Tide Inc.

Original: High Tide to Present at Several Major International Cannabis and Investor Conferences

High Tide Subsidiary NuLeaf Naturals Pursues Participation in U.S. Medicare CBD Pilot Launching TodayApril 1, 2026 9:12 AM
PR Newswire (Canada)

NuLeaf Naturals is Well Positioned to Serve as Supplier to Participating Organizations Under the CMS Innovation Center's Beneficiary Engagement IncentiveCALGARY, AB, April 1, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today announced that its wholly owned U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, intends to pursue participation in the U.S. Centers for Medicare & Medicaid Services (CMS) Innovation Center's Beneficiary Engagement Incentive ("BEI") pilot program as suppliers of eligible hemp-derived CBD products, and has already begun engaging with participating organizations.







The pilot program, which launched today, represents a significant step toward integrating hemp-derived CBD products into federally supported healthcare models. Under the program, participating Accountable Care Organizations (ACOs) under the ACO REACH Model and oncology practices under the Enhancing Oncology Model (EOM) may elect to furnish eligible hemp-derived products to Medicare beneficiaries at no cost, up to US$500 per year per beneficiary. CMS has indicated that the program may also expand to participants in its Long-term Enhanced ACO Design (LEAD) Model beginning January 1, 2027.NuLeaf Naturals, founded in 2014 in Denver, Colorado, is one of America's leading cannabinoid companies, with cGMP-certified and FDA-registered manufacturing facilities, with USDA Organic certification currently in process. NuLeaf's product portfolio includes THC-free and broad-spectrum CBD formats designed to align with the pilot program's compliance requirements, covering the full range of eligible product formats under the program.The Company's engagement with the CMS pilot program builds on the strategic foundation established through its founding membership in the National Compassionate Care Council (NCCC), a coalition of healthcare-focused organizations working to advance evidence-based cannabinoid policy and improve patient access to cannabinoid therapies across the United States."The launch of the CMS pilot program is a historic moment for the U.S. CBD industry and, most importantly, for the millions of Medicare beneficiaries who may now have access to hemp-derived cannabinoid therapies at no cost to themselves, with costs borne by participating organizations under CMS models," said Raj Grover, Founder and Chief Executive Officer of High Tide."NuLeaf Naturals has spent years building the quality systems, certifications, and product standards that this program demands. We believe NuLeaf is well positioned to serve as a trusted supplier to participating healthcare organizations, and we are actively engaging with ACOs and oncology programs to make that a reality. As this program scales, we believe it has the potential to become a meaningful growth driver for High Tide's U.S. CBD business," added Mr. Grover.Background on the Pilot ProgramOn December 18, 2025, the U.S. President signed an Executive Order advancing the rescheduling of cannabis and directing federal agencies to improve access to full-spectrum CBD products. As part of that announcement, CMS Administrator Dr. Mehmet Oz confirmed that the CMS Innovation Center would launch a pilot program allowing Medicare beneficiaries to receive eligible hemp-derived CBD products at no cost if recommended by their physicians.CMS has since published detailed guidance confirming that the BEI program will be available to participants in the ACO REACH Model and the Enhancing Oncology Model beginning April 1, 2026, with additional availability under the LEAD Model beginning January 1, 2027. Participating organizations must submit an implementation plan to CMS for approval, detailing the specific products, dosing information, beneficiary eligibility criteria, and safeguards to be employed. Medicare does not directly pay for the products; the cost is borne by the participating organization as part of its model participation.The program has been described by CMS as an opportunity to generate real-world clinical data on the use of hemp-derived CBD products within structured, physician-guided care settings, with the potential for full-reimbursement and expansion when supported by evidence.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 220 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany. Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.ABOUT NULEAF NATURALSFounded in 2014 in Denver, Colorado, NuLeaf Naturals is one of America's leading cannabinoid companies. Since its inception, the company has been committed to creating the world's highest-quality cannabinoid products in their purest and most potent form. Most of NuLeaf's products are produced at its cGMP-certified and FDA-registered facility, enabling it to manufacture ground-breaking cannabinoid formulations while exceeding the highest levels of regulatory compliance. Their cannabinoid products are sold direct-to-consumer from their website and are also available at select bricks-and-mortar stores across the U.S. The company is committed to creating safe, consistent, and effective products and has proudly received over 35,000 verified 5-star customer reviews through its e-commerce platform. ABOUT NATIONAL COMPASSIONATE CARE COUNCILHigh Tide, NuLeaf Naturals, and FAB CBD are founding members of the National Compassionate Care Council (NCCC), a coalition of healthcare-focused organizations dedicated to improving patient access to cannabinoid therapies by modernizing healthcare standards and advancing evidence-based policy. In addition to High Tide and its subsidiaries, founding members include Feals, Medterra CBD LLC, Tilray Inc., Realm of Caring, Lazarus Naturals, Constance CBD, and Equilibria. Through its participation in the NCCC, the Company aims to contribute industry expertise while supporting broader efforts to expand patient access to safe and effective cannabinoid therapies across the United States.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: whether the CMS pilot program will proceed as announced or expand beyond its initial scope; whether NuLeaf Naturals and FAB CBD will be selected as suppliers by participating organizations; whether the Company's U.S. CBD subsidiaries will benefit commercially from the pilot program; the potential for the pilot program to become a meaningful growth driver for the Company; the ability of the Company's products to meet the program's quality and compliance requirements; whether federal cannabis policy will continue to evolve favorably; and whether the NCCC will achieve its stated objectives. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-subsidiary-nuleaf-naturals-pursues-participation-in-us-medicare-cbd-pilot-launching-today-302731381.htmlSOURCE High Tide Inc.

Original: High Tide Subsidiary NuLeaf Naturals Pursues Participation in U.S. Medicare CBD Pilot Launching Today

High Tide Reports First Quarter 2026 Financial Results Featuring Record Revenue Exceeding $700 Million AnnualizedMarch 17, 2026 4:00 PM
PR Newswire (US)

Canna Cabana Remains the Largest Cannabis Retailer in Canada with 220 Current Locations The Company Reiterates its Long-Term Goal to Exceed 350 Locations Across CanadaThe Company Generated $2.9 Million in Free Cash Flow During the Quarter, Marking Significant Improvements Year Over Year and Sequentially. Over the Past 12 Months, the Company Has Generated $16.8 Million in Free Cash FlowCanadian Cabana Club Members Now Exceed 2.58 Million, Up 47% Year Over Year, Marking the Fastest Pace in 10 Quarters and Remains the Largest Cannabis Loyalty Program GloballyELITE Members in Canada Have Surpassed 162,000, Up 100% Year Over YearHigh Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars,1 and Continues to Hold a Leading 12% Share of the Cannabis Retail Market Across the Five Provinces in Which the Company Has a Presence, Up from 11% in the Same Period Last Year2Despite the Volume of Biomass Still in Portugal Waiting to be Released, Remexian Pharma GmbH Was Able to Significantly Increase its Market Share of German Imports From 6.5% for the Three Months Ended September 2025 to 10.3% for the Three Months Ended December 20253CALGARY, AB, March 17, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today released its financial results for the first fiscal quarter of 2026 ended January 31, 2026, the highlights of which are included in this news release. The full set of unaudited condensed interim consolidated financial statements for the three months ended January 31, 2026 and 2025 (the "Financial Statements") and accompanying management's discussion and analysis can be accessed by visiting the Company's website at www.hightideinc.com, its profile pages on SEDAR+ at www.sedarplus.ca, and EDGAR at www.sec.gov/edgar. __________1 Based on reporting by New Cannabis Ventures as of December 16, 2025. For the New Cannabis Ventures' senior listing, segmented cannabis-only sales must generate more than US$25 million per quarter (CAD$31 million) – for full details, see: https://www.newcannabisventures.com/cannabis-company-revenue-ranking/  2 Based on publicly available store count data for December 2025 and January 2026 in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulators3 Source: Germany's Federal Institute for Drugs and Medical Devices (BfArM) and internal Company data"We delivered another quarter of solid results, highlighted by record revenue, record gross profit, and positive free cash flow. Our innovative discount club model, built around customer loyalty, continues to be the backbone of our success. Cabana Club membership keeps growing rapidly, and our stores continue to outperform peers, while our core bricks-and-mortar segment achieved its fifth consecutive quarter of sequential gross margin improvement." "Internationally, our German business is gaining strong momentum. The first full fiscal quarter following our acquisition of Remexian exceeded our expectations, and since quarter-end we have seen further improvements in both revenue and margins. As we begin to realize success in Germany, we are also exploring additional international opportunities, including the United Kingdom, where we are engaging with major industry participants with the goal of entering the market through a potential M&A transaction within the next 12 months." "In the United States, our e-commerce businesses are beginning to show encouraging signs of recovery, with sequential revenue growth for the first time in two years. More importantly, we are positioning ourselves for what we believe could become a meaningful opportunity as regulations evolve around Medicare and Medicaid coverage for CBD products." "With strong momentum in Canada, expanding international opportunities, and improving prospects in the United States, the future for High Tide is bright and increasingly global. I want to thank our entire team for their outstanding execution and dedication."— Raj Grover, Founder and Chief Executive Officer of High TideFirst Fiscal Quarter 2026 – Financial Highlights:Revenue was a record $178.3 million for the three months ended January 31, 2026 compared to $142.5 million during the same period last year, an increase of 25% year over year, representing the fastest growth rate in 10 quarters. Revenue was up 9% sequentially during the the three months ended January 31, 2026. This was the third consecutive quarter marking a new all-time high in revenue.Gross profit was a record $44.4 million for the three months ended January 31, 2026, up 25% year over year and up 4% sequentially.Gross margin was 25% for the three months ended January 31, 2026, which was consistent year over year and compared to 26% sequentially. The margins in the Company's core bricks-and-mortar segment, which generated 84% of its revenue, increased sequentially for the fifth consecutive quarter, reaching 28%. As previously communicated, gross margins in its medical cannabis distribution segment were impacted by older biomass in Portugal which is being liquidated at prices lower than usual given their limited time to expiry. The Company expects to see improvements in gross margins in this segment starting in the second fiscal quarter of 2026, as biomass procured from Canada at best in class terms begins flowing through the supply chain and showing up in financial results.Adjusted EBITDA was $11.5 million in the three months ended January 31, 2026 representing the second-highest quarter ever, and compared to $7.1 million year over year, marking the fastest growth rate in eight quarters, and $12.4 million sequentially.  The Company generated $2.9 million in free cash flow in the three months ended January 31, 2026, representing a significant improvement from $(1.9) million year over year, and $1.3 million sequentially. During the past four quarters, the Company has generated $16.8 million in free cash flow.   General and administration expenses represented 4.1% of revenue in the three months ended January 31, 2026, which improved from 4.6% during the previous year, and 4.3% sequentially, and was the lowest level in six quarters.Salaries, wages, and benefits represented 11.8% of revenue in the three months ended January 31, 2026, which improved from 12.3% year over year and compared to 11.5% sequentially.  During the first fiscal quarter, the Company generated a net loss of $0.4 million, which represented meaningful improvements from a net loss of $2.7 million year over year and a net loss of $46.7 million sequentially, which was impacted by non-cash impairment expenses and charges related to changes in derivative liabilities.Cash and cash equivalents, including restricted cash, as at January 31, 2026 totaled $46.4 million, which compared to $33.3 million in the prior year, and $47.9 million sequentially.First Fiscal Quarter 2026 – Retail Highlights:Canadian Cabana Club membership has surpassed 2.58 million, an increase of 47% year over year, the fastest pace of growth in ten quarters, and remains the largest cannabis loyalty program globally. The Company has also exceeded 162,000 ELITE members in Canada, an increase of 100% year over year.Global Cabana Club membership, including Canada, has surpassed 6.65 million, up 17% year over year. This includes over 171,000 ELITE members, which grew by 100% year over year.The average Canna Cabana store generated 1.9x revenue versus peers.4Same-store sales were up 0.5% year over year in the first fiscal quarter of 2026, and down 1.3% sequentially on a daily basis. The Company notes that sales were negatively impacted by extremely harsh weather conditions in Ontario during January. Since the launch of its discount club model in October 2021, same store sales at Canna Cabana are up 149% while the average operator has experienced flat sales.5  Canna Cabana reached a 12% market share, up from 11% in the previous year.6Canna Cabana had a shrink rate of 0.3% during the three months ended January 31, 2026.Excluding stores open less than six months, annualized retail sales per square foot were $1,728 across the Canna Cabana store network during the first fiscal quarter of 2026, which was 4% lower year over year and 3% sequentially, having been impacted by harsh weather in Ontario. This was higher than many best-in-class international retailers.____________4 For the month of December 2025, based on publicly available store count data in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulators5 Calculated by chaining monthly data, and based on publicly available store count data in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulators6 For the months of November 2025 and December 2025, based on publicly available store count data in the five Canadian provinces where Canna Cabana operates and as per publicly available data from Statistics Canada and provincial regulatorsFirst Fiscal Quarter 2026 – Operational Highlights (November 1, 2025 – January 31, 2026):The Company opened seven new Canna Cabana locations across Alberta and Ontario—Scarborough, Kitchener, Nepean, London, Brampton, and two locations in Calgary—bringing the total Canna Cabana store count to 218 locations across Canada as at the end of the quarter.The Company welcomed the Alberta Gaming and Liquor Commission's decision to loosen restrictions on advertising and promotional relationships between licensed retailers and licensed producers.The Company has begun exploring pathways for its U.S. CBD brands, NuLeaf Naturals and FAB CBD, to participate in and capitalize on recently announced U.S. federal initiatives, including the anticipated launch of a Medicare pilot program that would allow eligible seniors to receive CBD products at no cost up to US$500 annually. The Company believes these developments may represent a meaningful growth opportunity for its U.S. CBD platforms and is evaluating strategic initiatives aligned with the emerging federal framework.The Company joined the National Compassionate Care Council in the United States, better positioning it to help shape relevant federal and state level legislative and regulatory reforms related to medical cannabis.The Company notes that its e-commerce segment is showing signs of stabilization, with revenue up 5% sequentially,  marking the first sequential quarterly improvement in two years, with the Adjusted EBITDA loss also improving by $0.2 million.Subsequent Events (February 1, 2026 - Present): The Company opened two new Canna Cabana locations in Ontario—Scarborough and Sarnia—bringing the total Canna Cabana store count to 220 locations across Canada.The Company announced the appointment of Kathleen Skerrett and Menashe Kestenbaum as directors of the Company, and the appointment of David Wallach and Filip Ernest as members of the Company's Advisory Board.First Fiscal Quarter 2026 – Medical Cannabis UpdateThe first fiscal quarter of 2026 marked High Tide's first full quarter operating in the medical cannabis sector following its acquisition of a majority stake in Remexian. The segment generated revenue of $25.0 million during the first fiscal quarter of 2026, marking an improvement versus $9.8 million in revenue for the two months for which the segment contributed to financial results during the fourth fiscal quarter of 2025. The Company notes that the segment has shown continued growth subsequent to the end of the first fiscal quarter. In February, Remexian sold 2.6 tonnes of medical cannabis, generating revenue of €7.5 million (C$12 million) with a preliminary gross margin of 20%.Total industry imports of medical cannabis into Germany reached 201 tonnes in 2025, a 176% increase compared to 73 tonnes in the prior year.7 Canada was the leading country of origin, accounting for 93 tonnes, nearly 50% of total German imports. Portugal ranked second at 55 tonnes, which frequently serves as an intermediary supplier of Canadian medical cannabis products.8Despite the volume of biomass still in Portugal waiting to be released, Remexian was able to significantly increase its market share of German imports from 6.5% for the three months ended September 2025 to 10.3% for the three months ended December 2025.9More than 1 in 7 German pharmacies now offer cannabis for medical use, reflecting continued market expansion.10___________7 Source: Germany's Federal Institute for Drugs and Medical Devices (BfArM)8 Source: Germany's Federal Institute for Drugs and Medical Devices (BfArM)9 Source: Germany's Federal Institute for Drugs and Medical Devices (BfArM) and internal Company data10 Source: German Cannabis Business Association (BvCW)Selected financial information for the Three Months Ended January 31, 2026:
(Expressed in thousands of Canadian Dollars)

Three Months Ended January 31,

2026
2025
Change  

$
$
?Free cash flow(i)
2,939
(1,900)
255 %Net cash provided by operating activities
5,860
682
759 %Revenue
178,329
142,461
25 %Gross profit
44,409
35,440
25 %Gross profit margin(ii)
25 %
25 %
— %Operating expense(iii)
(33,642)
(28,351)
19 %Operating expense as a % of revenue(iv)
19 %
20 %
(1) %Total expenses
(42,038)
(35,373)
19 %Income from operations
2,371
67
— %Adjusted EBITDA(v)
11,457
7,089
62 %Adjusted EBITDA as a percentage of revenue(vi)
6 %
5 %
1 %Net loss
(352)
(2,689)
87 %Basic and diluted income (loss) per share
0.01
(0.03)
— %i.Free cash flow is a non-IFRS financial measure prepared based on the calculation below.ii.Gross margin is  a non-IFRS financial measure. Gross margin is calculated by dividing gross profit by revenue.iii.Operating expense is a non-IFRS measure and includes salaries, wages and benefits, general & administration, professional fees, advertising & promotion, and interest & bank charges.iv. Operating expense as a % of revenue is a non-IFRS financial measure. This metric is calculated as operating expense divided by revenue.v.Adjusted EBITDA is a non-IFRS financial measure. A reconciliation of the Adjusted EBITDA to Net income (loss) is found below.vi.Adjusted EBITDA as a percentage of revenue is a non-IFRS financial measure. This metric is calculated as adjusted EBITDA divided by revenue.The reconciling items between net earnings, EBITDA, and Adjusted EBITDA are as follows:
2026
2025

2024
Q1  Q4  Q3  Q2  Q1  Q4  Q3  Q2  Net (loss) Income(352)(46,711)832(2,836)(2,689)(4,802)825171Income/deferred tax recovery (expense)40(178)694638(153)671(878)Accretion and interest3,1551,2131,7951,9502,1012,3081,6811,712Depreciation and amortization8,0266,5036,0805,8805,8475,3625,6787,505EBITDA(i)10,869(39,173)8,7765,0405,2972,7158,8558,510Inventory fair value690865——————Foreign exchange (gain) loss(144)333120114(13)519(5)Transaction and acquisition costs2,9582,6828811,616630773121,314Other (gain) loss—(41)(1)42—(874)6337Impairment loss—23,564———4,964——Share-based compensation 3706688241,2501,175750881549Gain on revaluation of debenture———————(240)(Gain) loss on fair value change in derivative liability(3,286)23,51643——(88)(159)(110)Gain on extinguishment of financial liability———————(314)Adjusted EBITDA(i)11,45712,41410,6438,0627,0898,2459,61410,041Adjusted EBITDA margin(ii)6 %8 %7 %6 %5 %6 %7 %8 %i.EBITDA and Adjusted EBITDA are non-IFRS financial measures.ii.Adjusted EBITDA margin is a non-IFRS financial measure. This metric is calculated as Adjusted EBITDA divided by revenue.
202620252024
Q1Q4 Q3 Q2 Q1 Q4 Q3Q2 Cash flow from operating activities 5,4866,5998,2314,6864,6446,1798,9288,032Changes in non-cash working capital374(2,321)2,4193,569(3,961)3,473(2,715)4,777Net cash provided by operating activities 5,8604,27810,6508,2556839,6526,21312,809Sustaining capex(i)(286)(345)(460)(692)(361)(533)(279)(528)Lease liability payments(2,635)(2,610)(2,508)(2,667)(2,222)(3,211)(2,842)(2,898)Free cash flow(ii)2,9391,3237,6824,896(1,900)5,9083,0929,383Free cash flow - trailing twelve months16,84012,00116,58611,99616,48321,99121,77022,729i.Sustaining capex is a non-IFRS measure.ii.Free cash flow is a non-IFRS measure.OUTLOOKBricks-and-Mortar Retail High Tide's wholly owned subsidiary, Canna Cabana, is the largest cannabis retail chain in Canada with 220 current operating locations. The Company anticipates that it will advance toward its long-term goal of surpassing 350 locations nationwide by opening another 20-30 locations in calendar 2026, mostly through organic growth, while also evaluating supplemental M&A opportunities of varying sizes.The Company continues to expand its white label cannabis product portfolio under its flagship Queen of Bud and Cabana Cannabis Co. brands, reaching 35 SKUs across the Canna Cabana store network as at the end of the first fiscal quarter. The Company is also developing several new offerings to further grow its white label portfolio. Currently, white label cannabis SKUs represent approximately 1.6% of the Company's total bricks-and-mortar cannabis sales. Over the long term, the Company anticipates significant growth in its white label portfolio and expects sales of its higher-margin white label brands to reach approximately 20% of total sales.Cabana Club & ELITEThe Company's Cabana Club and ELITE loyalty programs, which remain the largest such cannabis loyalty programs in the world, continue to expand at a rapid pace across Canada. Cabana Club membership has now surpassed 2.58 million members in Canada, which is up 47% in the past year. Over the long term the Company anticipates exceeding 3 million Cabana Club members in Canada. Globally, the Company has now surpassed 6.65 million Cabana Club members. ELITE, the paid membership tier now exceeds 162,000 members in Canada—after growing by 100% year over year—and 171,000 worldwide, with additional members being onboarded daily. The Company's long term goal is to have 1 million ELITE members within the Cabana Club. ELITE members tend to shop more frequently and in larger quantities than base tier members.United StatesConsistent with its prior disclosure, the Company has been evaluating various alternatives regarding its e-commerce division, which currently represents 2% of its consolidated revenue. The Company is pleased to report that its e-commerce businesses are beginning to show encouraging signs of recovery sequentially, with revenue increasing and improvements across the business.On December 18, 2025, U.S. President Donald Trump signed an Executive Order advancing the rescheduling of cannabis and announced that the Centers for Medicare & Medicaid Services is expected to launch a pilot program allowing seniors who are Medicare beneficiaries to receive CBD products at no cost up to US$500 per year. In response, the Company, and its leading U.S. hemp-derived CBD subsidiary, NuLeaf Naturals, have become founding members of the U.S. National Compassionate Care Council, which aims to play a significant role in bridging the nexus between patients, researchers and policy makers.EuropeAs noted previously, gross margins in the medical cannabis distribution segment were impacted by the liquidation of older biomass in Portugal at below-average prices due to limited time to expiry. Nonetheless, in the first fiscal quarter of 2026, Remexian generated $25 million in revenue, which is nearly 70% higher than the pace of the prior quarter. And in February 2026, distribution from Remexian was 2.6 tonnes, and represented the highest revenue generating month—with revenue surpassing $12 million—since the Company acquired a majority stake in Remexian in September 2025. The Company expects gross margin improvement beginning in the second quarter of 2026, as Canadian biomass procured at best-in-class terms begins flowing through the supply chain.Given the Company's intention to expand into other European countries, it continues to deepen its understanding of the United Kingdom market and its key players, and anticipates entering the market within the next 12 months through a merger or acquisition.Free Cash Flow The Company continues to gain strong traction in its strategic objective of procuring additional supply for Remexian and remains optimistic that sales will accelerate in the coming quarters, supported by continued momentum in the established German medical cannabis market, and growing interest from other emerging international markets.The Company highlights the significantly increased level of revenue at Remexian since its acquisition in September 2025. The Company is pleased with the segment's growth trajectory and expects Remexian's operations to continue to expand. The Company notes that there is a meaningful delay between paying deposits to suppliers, and when the Company receives cash from its customers in Germany. As such, the Company is evaluating its working capital needs to fund this profitable growth.ATM PROGRAM QUARTERLY UPDATEThe Company has not issued equity via an ATM Program for the last four fiscal quarters.During the three months ended January 31, 2025, the Company issued an aggregate of 11,600 Common Shares over the Nasdaq or TSXV, for aggregate gross proceeds of $52. Pursuant to the Equity Distribution Agreement cash commission of $1 on the aggregate gross proceeds raised was paid to the Agents in connection with their services under the Equity Distribution Agreement during the year ended October 31, 2025.This ATM Program was effective until July 24, 2025, when the Canadian Shelf Prospectus was withdrawn in order to file a new base shelf prospectus.On August 11, 2025, the Company filed a final short form base shelf prospectus in all Canadian provinces and territories and a corresponding shelf registration statement with the U.S. Securities and Exchange Commission. The Company's current ATM Program allows the Company to issue up to $100,000 (or the equivalent in U.S. dollars) of Common Shares from the treasury to the public from time to time, at the Company's discretion and subject to regulatory requirements, as required pursuant to National Instrument 44-102 – Shelf Distributions and the policies of the TSXV.As at the date the financial statements were authorized for issue, no securities had been issued under the shelf and no at-the-market distribution agreement or prospectus supplement had been entered into.WEBCAST LINK FOR TIDE EARNINGS EVENT The Company will host a webcast and conference call to discuss its audited results and outlook at 11:30 AM (Eastern Time) on Wednesday, March 18, 2026.https://app.webinar.net/XVw7dN1x5Z6 Participants are encouraged to pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above. Participants who wish to ask questions during the event may do so through the call-in line, the access information for which is as follows: North American Toll Free: 1-888-510-2154
International Toll Free (Germany): 498005889782ABOUT HIGH TIDE High Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada with 220 domestic locations and 1 international location. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. In 2025, the Company became the first North American cannabis operator to launch a bricks-and-mortar presence in Germany. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Manager
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.com CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS  This press release may contain "forward-looking information" and "forward-looking statements" within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: The Company's business objectives and milestones and the anticipated timing of, and costs in connection with, the execution or achievement of such objectives and milestones (including, without limitation, proposed acquisitions, expansions and store openings); the Company's future growth prospects and intentions to pursue one or more viable business opportunities; the development of the Company's business and future activities following the date hereof; expectations relating to market size and anticipated growth in the jurisdictions within which the Company may from time to time operate or contemplate future operations; expectations with respect to economic, business, regulatory, or competitive factors related to the Company or the cannabis industry generally; the market for the Company's current and proposed product offerings, as well as the Company's ability to capture market share; the distribution methods expected to be used by the Company to deliver its product offerings; the Company's strategic investments and capital expenditures, and related benefits; changes in general and administrative expenses; future business operations and activities and the timing and performance thereof; the future tax liability of the Company; the estimated future contractual obligations of the Company; the future liquidity and financial capacity of the Company and its ability to fund its working capital requirements and forecasted capital expenditures; the competitive landscape within which the Company operates and the Company's market share or reach; the Company adding the number of additional cannabis retail store locations the Company proposes to add to the Company's business upon the timelines indicated herein; the Company remaining on a positive growth trajectory; same-store sales continuing to increase; the Company making increases to its revenue profile; the Company completing the development of its cannabis retail stores; the Company's ability to generate positive free cash flow and remain free cash flow positive for the fiscal year; free cash flow allowing the Company to finance its growth with internal cash flows; the Company's ability to maximize shareholder value; the Company's ability to obtain, maintain, and renew or extend, applicable authorizations, including the timing and impact of the receipt thereof; the realization of cost savings, synergies or benefits from the Company's recent and proposed acquisitions; the Company's ability to successfully integrate the operations of any business acquired within the Company's business; the anticipated sales from continuing operations; the ability of the company to use cash generated from existing operations to fund future locations; Cabana Club and ELITE loyalty programs membership continuing to increase; the anticipated changes to and effects of the ELITE program on the business and operations of the Company; the Company hitting its forecasted revenue and sales projections; the intention of the Company to complete any offering of securities of the Company; the aggregate amount of the total proceeds that the Company will receive pursuant to any future offering; the Company's expected use of the net proceeds from the ATM Program and/or any future offering; the listing of Common Shares offered in the ATM Program and/or any future offering; the anticipated effects of the ATM Program and/or any future offering on the business and operations of the Company; the Company's ability to enter emerging legal cannabis jurisdictions, the ability of the Company to capture additional market share in the amount and on the timelines indicated herein; the ability of the Company to add 20-30 stores this calendar year and reach its goals of 350 stores nationwide, 1 million ELITE members, and 3 million Cabana Club members in Canada, the timeline for the ending of supply chain disruptions in Portugal related to Remexian; sales from Remexian accelerating; improvements in Remexian's gross margins in Q2 2026; whether additional working capital will be needed to grow Remexian; the ability to remain free cash flow positive for the 2026 fiscal year; the closing of announced acquisitions, the ability of the Company to develop and launch cannabis, white label, and consumption accessory offerings and for sales of its higher-margin white label brands to grow to 20%; the continued stabilization and improvement of e-commerce platforms, the ability to fund store growth internally; the entering of a potential M&A deal and ability of the company to enter the U.K. in the next 12 months; and the ability of the Company and its subsidiaries to capitalize on further federal reforms in the U.S. and elsewhere, including Medicare and Medicaid and for these to be a growth opportunity for the Company.Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. CAUTIONARY NOTE REGARDING FUTURE ORIENTED FINANCIAL INFORMATION  This press release may contain future oriented financial information ("FOFI") within the meaning of applicable securities legislation about prospective results of operations, financial position or cash flows, which is subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above "Cautionary Note Regarding Forward-Looking Statements". FOFI is not presented in the format of a historical balance sheet, income statement or cash flow statement. FOFI does not purport to present the Company's financial condition in accordance with IFRS as issued by the International Accounting Standards Board, and there can be no assurance that the assumptions made in preparing the FOFI will prove accurate. The actual results of operations of the Company and the resulting financial results will likely vary from the amounts set forth in the analysis presented, and such variation may be material (including due to the occurrence of unforeseen events occurring subsequent to the preparation of the FOFI). The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments as of the applicable date. However, because this information is highly subjective and subject to numerous risks, readers are cautioned not to place undue reliance on the FOFI as necessarily indicative of future results. Except as required by applicable securities laws, the Company undertakes no obligation to update such FOFI. Importantly, the FOFI contained in this press release are, or may be, based upon certain additional assumptions that management believes to be reasonable based on the information currently available to management, including, but not limited to, assumptions about: (i) the future pricing for the Company's products, (ii) the future market demand and trends within the jurisdictions in which the Company may from time to time conduct the Company's business, (iii) the Company's ongoing inventory levels, and operating cost estimates, and (iv) the Company's net proceeds from the ATM Program and future financings. The FOFI or financial outlook contained in this press release do not purport to present the Company's financial condition in accordance with IFRS as issued by the International Accounting Standards Board, and there can be no assurance that the assumptions made in preparing the FOFI will prove accurate. The actual results of operations of the Company and the resulting financial results will likely vary from the amounts set forth in the analysis presented in any such document, and such variation may be material (including due to the occurrence of unforeseen events occurring subsequent to the preparation of the FOFI). The Company and management believe that the FOFI has been prepared on a reasonable basis, reflecting management's best estimates and judgments as at the applicable date. However, because this information is highly subjective and subject to numerous risks including the risks discussed under the heading above entitled "Cautionary Note Regarding Forward-Looking Statements" and under the heading "Risk Factors" in the Company's public disclosures, FOFI or financial outlook within this press release should not be relied on as necessarily indicative of future results. Readers are cautioned not to place undue reliance on the FOFI, or financial outlook contained in this press release. Except as required by Canadian securities laws, the Company does not intend, and does not assume any obligation, to update such FOFI.














View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-reports-first-quarter-2026-financial-results-featuring-record-revenue-exceeding-700-million-annualized-302716464.htmlSOURCE High Tide Inc.

Original: High Tide Reports First Quarter 2026 Financial Results Featuring Record Revenue Exceeding $700 Million Annualized

High Tide Opens 220th Canna Cabana in Sarnia, OntarioMarch 6, 2026 6:00 AM
PR Newswire (US)

The Company Also Announces the Details of the Release of Its Upcoming First Quarter 2026 Financial Results CALGARY, AB, March 6, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 1355 London Road in Sarnia, Ontario, will begin selling recreational cannabis products and consumption accessories for adult use on March 9, 2026. This opening brings High Tide's total store count to 220 Canna Cabana locations across Canada and 96 in the province of Ontario.







This location marks the Company's first entry into the Sarnia market and represents a strong demographic fit as it expands further into Southwestern Ontario. Strategically positioned in the city's east end along London Road, the site offers excellent visibility within a well-established commercial node directly across Lambton Mall. The store benefits from a highly complementary tenant mix, co-tenanted with nationally recognized retailers in addition to a concentration of big-box retail located directly across the street."I am pleased to announce our entry into the Sarnia market as we continue expanding into high-potential communities across Canada where Canna Cabana does not yet have a presence," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Sarnia offers a strong demographic profile for cannabis retail, and we believe our discount club model will resonate well with local consumers seeking value, selection, and a differentiated retail experience.""While we are proud to have reached 220 stores nationwide, Canada still presents meaningful opportunities for continued organic expansion. Our approach remains disciplined and data-driven, focusing on quality locations and communities where the fundamentals support long-term growth," added Mr. Grover.WEBCAST LINK FOR HIGH TIDE EARNINGS EVENTThe Company also announces that it will release its financial and operational results for the quarter ended January 31, 2026, after financial markets close on Tuesday, March 17, 2026. High Tide's first fiscal quarter 2026 financial and operational results will be available on SEDAR+, EDGAR, and on the Company's website at https://hightideinc.com/invest. Following the release of its first fiscal quarter financial and operational results, High Tide will host a webcast with Raj Grover, Founder and Chief Executive Officer, and Mayank Mahajan, Chief Financial Officer, to discuss the Company's financial results and what the remaining fiscal year holds for High Tide, at 11:30 AM Eastern Time on Wednesday, March 18, 2026.https://app.webinar.net/XVw7dN1x5Z6Participants are encouraged to pre-register for the webcast by clicking on the link above prior to the beginning of the live webcast. Three hours after the live webcast, a replay of the webcast will be available at the same link above.Participants who wish to ask questions during the event may do so through the call-in line, the access information for which is as follows: North American Toll Free: 1-888-510-2154
International Toll Free (Germany): 498005889782ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 220 domestic locations. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the timing of the new locations opening and beginning to sell recreational cannabis products and consumption accessories for adult use; the expected benefits of the store locations; and the level of competition in the area. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-opens-220th-canna-cabana-in-sarnia-ontario-302706320.htmlSOURCE High Tide Inc.

Original: High Tide Opens 220th Canna Cabana in Sarnia, Ontario

High Tide Announces Appointment of Two New Directors, and Appointment of Two Advisors with Focus on Real Estate and Artificial IntelligenceMarch 3, 2026 6:00 AM
PR Newswire (US)

CALGARY, AB, March 3, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today changes to its Board of Directors (the "Board") as part of a planned board renewal process.







Board TransitionsThe Company announces that Nitin Kaushal and Andrea Elliott have resigned from the Board, effective March 2, 2026. On behalf of the Board and management, the Company thanks Mr. Kaushal, on the board since 2018, and Ms. Elliott, on the board since 2021, for their dedicated service and significant contributions to High Tide during a period of substantial growth and strategic development, which entailed each of them investing material time and effort to support the Company. In addition to their exemplary service as members of the Board, Mr. Kaushal served as Chair of the Audit Committee and Ms. Elliott served as Chair of the Compensation Committee.  "I want to personally thank both Nitin and Andrea for their years of service on the Board," said Raj Grover, Founder and Chief Executive Officer of High Tide. "They each played an important role during a critical chapter of High Tide's development, and we wish them well in their future endeavours."Appointment of New DirectorsThe Board is pleased to announce the appointment of Kathleen Skerrett and Menashe Kestenbaum as directors of the Company, effective March 2, 2026."High Tide has built a strong foundation over the past several years, and every member of this Board, past and present, has contributed to getting us here. As we enter our next chapter, our needs as a company are evolving. We are now a dual-listed, international platform operating at significant scale, and our board and advisory composition must evolve to match the complexity and ambition of what lies ahead. Kathleen brings deep securities and governance expertise directly relevant to our listing structure and growth trajectory, Menashe adds proven experience scaling public technology platforms and navigating multi-exchange governance, David strengthens our strategic real estate positioning, and Filip enhances our long-term digital and AI capabilities. These appointments are a deliberate step forward to ensure High Tide has the right leadership bench for the global opportunity in front of us," added Mr. Grover.About Kathleen SkerrettKathleen Skerrett is a Partner at Gardiner Robers LLP, where she practices in the areas of securities law, corporate governance, and capital markets transactions. Ms. Skerrett has extensive experience advising public companies on M&A transactions, regulatory compliance, and continuous disclosure obligations. She has particular expertise advising emerging and mid-cap issuers listed on the TSX Venture Exchange, the CSE, and NASDAQ on complex transactional and governance matters, including MI 61-101 compliance, take-over bid regulations, and cross-border securities issues. Ms. Skerrett has been recognized by Best Lawyers Canada and Chambers for her securities law expertise. She holds a law degree and B.Comm from University of Toronto and is a member of the Law Society of Ontario.About Menashe KestenbaumMenashe Kestenbaum is a seasoned technology entrepreneur, industry disruptor, public company executive, and venture capital investor. Mr. Kestenbaum started off in the gaming industry, leading Enthusiast Gaming from its beginnings as a basement startup in 2015, through an IPO, to an all-time high of a $1.4B market cap in 2021. He is also a General Partner of LeverageVC, a venture capital fund focused on early-stage technology investments, including having made investments in AI and e-commerce. Menashe has now turned his focus onto disrupting the mental health industry with Glimmer, where he acts as CEO. Mr. Kestenbaum brings deep expertise in scaling technology companies, navigating public company governance across multiple exchanges, and evaluating emerging technology and AI opportunities. His experience managing dual-listed companies on the TSX and NASDAQ is directly relevant to High Tide's listing structure.Appointment of David Wallach and Filip ErnestThe Company is also pleased to announce the appointment of David Wallach, CCIM, and Filip Ernest as a member of the Company's Advisory Board, to provide strategic guidance to management on matters including real estate, business development, artificial intelligence, e-commerce technology and community and stakeholder engagement.About David WallachDavid Wallach is the Owner and President of Barclay Street Real Estate Ltd., a leading Calgary-based commercial real estate brokerage and property management firm that he has built over more than two decades into one of Western Canada's premier boutique commercial real estate platforms. Mr. Wallach has supervised in excess of $500 million in real estate transactions and has extensive experience in investment sales, property management, and business operations. He holds the Certified Commercial Investment Member (CCIM) designation, one of the most recognized credentials in commercial real estate. Mr. Wallach is also the President and Founder of the Triumph Real Estate Investment Fund, serves as Treasurer on the Board of Directors of TCN Worldwide Real Estate Services, and is a member of the Dean's Advisory Board of Mount Royal University's Faculty of Business, Communication Studies and Aviation. Mr. Wallach is an active member of the Calgary business community, including as co-host of CORUS Entertainment's Calgary Next radio show profiling Calgary-based businesses and entrepreneurs.About Filip ErnestFilip Ernest is an entrepreneur and digital transformation strategist with more than two decades of experience building and scaling technology-driven businesses. His career began at the start of the commercial internet era in the Netherlands, where he was involved in one of the country's early internet agencies, helping companies establish their first digital infrastructure and online commerce capabilities.Over the past 25 years, Mr. Ernest has focused on developing scalable e-commerce platforms, data-driven operating systems, and technology-enabled consumer ecosystems across international markets. He is recognized for combining long-term strategic thinking with hands-on technical execution, particularly in areas where technology reshapes traditional retail and community models.Since 2022, Mr. Ernest has concentrated his work on artificial intelligence, machine learning, and adaptive systems, with an emphasis on integrating AI into operational workflows, customer engagement models, and decision-making frameworks. His work centers on positioning AI not as a standalone tool, but as a foundational layer within modern retail and digital enterprises.Grant of Options and RSUsThe Company also granted an aggregate of 123,558 restricted stock units of the Company (the "RSUs") and 25,000 options of the Company (the "Options") to directors, advisory board members, and consultants of the Company. Each RSU entitles the holder to acquire one common share of the Company upon vesting. Each Option entitles the holder to acquire one common share of the Company upon vesting, at a price of $3.43 per share for a period of three years.All RSUs and Options were granted in accordance with the Company's Omnibus Plan, which became effective on June 2, 2022. The common shares underlying the RSUs and Options set out above are subject to a statutory four month and one day hold period, and such further restrictions as may apply under foreign securities laws.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 219 domestic locations. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the future success and growth of the Company and its ability to capitalize on global opportunities. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-appointment-of-two-new-directors-and-appointment-of-two-advisors-with-focus-on-real-estate-and-artificial-intelligence-302701823.htmlSOURCE High Tide Inc.

Original: High Tide Announces Appointment of Two New Directors, and Appointment of Two Advisors with Focus on Real Estate and Artificial Intelligence

HITI.........................https://stockcharts.com/sc3/ui/?s=HITI&p=w&b=5&g=0&id=p86431144783

High Tide Opens New Canna Cabana in Scarborough, OntarioFebruary 9, 2026 8:00 AM
PR Newswire (Canada)

CALGARY, AB, Feb. 9, 2026 /CNW/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 3148 Kingston Road in Scarborough, Ontario, began selling recreational cannabis products and consumption accessories for adult use today on February 9, 2026. This opening brings High Tide's total store count to 219 Canna Cabana locations across Canada and 95 in the province of Ontario.







This new Canna Cabana location in Scarborough is strategically located along Kingston Road, a major east–west thoroughfare with strong visibility and high daily traffic volumes. The store serves an immediate trade area with limited nearby cannabis competition and benefits from convenient access to surrounding residential neighbourhoods. Previously occupied by Rockwood Cannabis, which performed well in this market, the location offers a proven foundation for continued success."This store opening reflects our continued focus on disciplined expansion and our commitment to opening locations that meet our strict financial and operational criteria," said Raj Grover, Founder and Chief Executive Officer of High Tide. "Situated in a dense and growing neighbourhood, this location represents a compelling opportunity to further strengthen our Ontario footprint through a well-positioned site with a strong history of retail performance.""We look forward to welcoming this store into the Canna Cabana network and leveraging our proven operating model, pricing leadership, and loyalty ecosystem to drive incremental performance," added Mr. Grover.Grant of Options and RSUsThe Company also announces that it has granted options to purchase an aggregate of 145,500 common shares of the Company (the "Stock Options") to certain employees and consultants of the Company. The Stock Options are exercisable at a price of $3.22 per share until February 6, 2029, and vest over two years.The Company also granted an aggregate of 1,300,530 restricted stock units of the Company (the "RSUs") to certain directors, officers, employees and consultants of the Company. 48% of the RSUs vest on February 6, 2027, 26% on February 6, 2028 and the remaining 26% on February 6, 2029. Each RSU entitles the holder to acquire one common share of the Company upon vesting.All Stock Options and RSUs were granted in accordance with the Company's Omnibus Plan, which became effective on June 2, 2022. The common shares underlying the Stock Options and RSUs set out above are subject to a statutory four month and one day hold period, and such further restrictions as may apply under foreign securities laws.As directors of the Company received an aggregate of 795,106 RSUs, the granting of RSUs represents a related-party transaction under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The participation of the related parties of the Company is exempt from the formal valuation and minority shareholder approval requirements provided under MI 61-101 in accordance with sections 5.5(a) and 5.7(1)(1) of MI 61-101, as neither the fair market value of the subject matter of the transaction, nor the consideration, exceed 25% of the Company's market capitalization. The Company did not file a material change report related to the RSUs more than 21 days before the grant as required by MI 61-101 but believes that this shorter period is reasonable and necessary in the circumstances.ABOUT HIGH TIDEHigh Tide, Inc. is the leading community-grown, retail-forward cannabis enterprise engineered to unleash the full value of the world's most powerful plant. Its wholly owned subsidiary, Canna Cabana, is the second-largest cannabis retail brand globally. High Tide (HITI) is uniquely-built around the cannabis consumer, with wholly-diversified and fully-integrated operations across all components of cannabis, including:Retail: Canna Cabana™ is the largest cannabis retail chain in Canada, with 219 domestic locations. The Company's Canadian bricks-and-mortar operations span British Columbia, Alberta, Saskatchewan, Manitoba, and Ontario, holding a growing 12% share of the market. In 2021, Canna Cabana became the first cannabis discount club retailer in the world. The Company also owns and operates multiple global e-commerce platforms offering accessories and hemp-derived CBD products.Medical Cannabis Distribution: Remexian Pharma GmbH is a leading German pharmaceutical company built for the purpose of importation and wholesale of medical cannabis products at affordable prices. Among all German medical cannabis procurers, Remexian has one of the most diverse reaches across the globe and is licensed to import from 19 countries including Canada.High Tide consistently moves ahead of the currents, having been named one of Canada's Top Growing Companies by the Globe and Mail's Report on Business in 2025 for the fifth consecutive year and was recognized as a top 50 company by the TSX Venture Exchange (the "TSXV") in 2022, 2024 and 2025. High Tide was also ranked number one in the retail category on the Financial Times list of Americas' Fastest Growing Companies for 2023. To discover the full impact of High Tide, visit www.hightideinc.com. For investment performance, don't miss the High Tide profile pages on SEDAR+ and EDGAR.Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.CONTACT INFORMATIONMedia Inquiries
Carter Brownlee
Communications and Public Affairs Advisor
High Tide Inc.
cbrownlee @rclark1223-3080Investor Inquiries
Vahan Ajamian
Capital Markets Advisor
High Tide Inc.
vahan@hightideinc.comCAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTSThis press release may contain "forward-looking information" and "forward-looking statements within the meaning of applicable securities legislation. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking statements herein include, but are not limited to, statements regarding: the timing of the new locations opening and beginning to sell recreational cannabis products and consumption accessories for adult use; the expected benefits of the store locations; and the level of competition in the area. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at www.sedarplus.ca and www.sec.gov, which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.










View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-opens-new-canna-cabana-in-scarborough-ontario-302682125.htmlSOURCE High Tide Inc.

Original: High Tide Opens New Canna Cabana in Scarborough, Ontario

In Low Pole Reversal mode since 23 Dec 2025. GLTA

HITI........................................................p/m

hiti.............................................https://stockcharts.com/h-sc/ui?s=hiti&p=W&b=5&g=0&id=p86431144783

Yup…was just gonna post…🥳

HITI.......................................................a/h

HITI..............................................https://stockcharts.com/h-sc/ui?s=HITI&p=W&b=5&g=0&id=p86431144783

HITI...$3.43...🥳...Bullish Engulfing Reversal Candle...

HITI.....................................https://stockcharts.com/h-sc/ui?s=HITI&p=W&b=5&g=0&id=p86431144783

TDR interview with Raj in Germany starts at 1:32:00

https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/dea-in-marijuana-crisis-calls-for-termination-of-key-officials-amid-c-1034348

Should be mostly up from here, on the way to another Golden Cross, imo. GLTA !

Death Cross hit today as the falling 50 dma crossed below the falling 200 dma.

50 dma now down to .16 above the 200 dma, the previous several days of price dip consolidation NOT confirming the integrity of the Golden Cross anymore (price below $2.30 US). *Note that this is the 28th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP $2.17 US, uP today
Close $2.16 US, uP today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/17/25: Q1 2025 Earnings Report, record revenues!
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere below the 200 dma.
Average VWAP is $2.13 the last 4 days. Political uncertainty is a downer. Time will tell...

50 dma now down to .18 above the 200 dma, the previous several days of price dip consolidation NOT confirming the integrity of the Golden Cross anymore *Note that this is the 27th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.13 US, uP today
Close $2.14 US, Down today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/17/25: Q1 2025 Earnings Report, record revenues!
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere below the 200 dma.
Average VWAP is 2.12 the last 3 days. Political uncertainty is a downer. Time will tell...

50 dma now down to .20 above the 200 dma, the previous several days of price dip consolidation NOT confirming the integrity of the Golden Cross anymore *Note that this is the 26th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.11 US, Down today
Close $2.15 US, uP today.
Volume was more than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/17/25: Q1 2025 Earnings Report, record revenues!
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere below the 200 dma. Political uncertainty is a downer.
HITI is still a better stock to own than TSLA, lol. Time will tell...

50 dma now down to .23 above the 200 dma, the previous several days of price dip consolidation NOT confirming the integrity of the Golden Cross anymore *Note that this is the 25th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.12 US, Down today
Close $2.07 US, Down today.
Volume was almost 3X the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/17/25: Q1 2025 Earnings Report, record revenues!
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere below the 200 dma. Political uncertainty is a downer.
HITI is still a better stock to own than TSLA, lol. Time will tell...

50 dma now down to .25 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross *Note that this is the 24th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.40 US, uP today
Close $2.43 US, uP today.
Volume was more than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/17/25: Q1 2025 Earnings Report, record revenues!
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere around the 200 dma. Political uncertainty is a downer.
HITI is still a better stock to own than TSLA, lol. Time will tell...

Q1 Earnings Report released:
https://www.stocktitan.net/news/HITI/high-tide-reports-first-quarter-2025-financial-results-featuring-89avrdn6fm0x.html#:~:text=(HITI)%20reported%20record%20Q1%202025,growth%20year%2Dover%2Dyear.

50 dma now down to .27 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross *Note that this is the 23rd day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.34 US, uP today
Close $2.36 US, uP today.
Volume was more than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/10/25: 2 new CC store openings in Ontario.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere below the 200 dma. Political uncertainty is a downer.
HITI is still a better stock to own than TSLA, lol. Time will tell...

https://stratcann.com/financials/sndl-secures-5-4-of-high-tides-shares/

50 dma now down to .28 above the 200 dma, the previous several days of price dip consolidation not confirming the integrity of the Golden Cross anymore, and now suggesting a move toward a Death Cross. *Note that this is the 22nd day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is holding flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.21 US, Down today
Close $2.19 US, Down today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/10/25: 2 new CC store openings in Ontario.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line somewhere below the 200 dma. Political uncertainty is a downer.
HITI is still a better stock to own than TSLA, lol. Time will tell...

https://stratcann.com/other/updates-cannabis-rules-regulations-now-public/

50 dma now down to .30 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross. *Note that this is the 21st day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is Down to $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.31 US, Down today
Close $2.29 US, Down today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/10/25: 2 new CC store openings in Ontario.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line between $2.30-$2.40, below the 200 dma. Political uncertainty is a downer. Time will tell...

50 dma now down to .31 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross. *Note that this is the 20th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is flat at $2.50, and the price closed below it for the first time on 2/27/25.
VWAP 2.32 US, uP today
Close $2.30 US, even today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 3/10/25: 2 new CC store openings in Ontario.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line between $2.30-$2.40, below the 200 dma. Political uncertainty is a downer. Time will tell...

https://www.prnewswire.com/news-releases/high-tide-to-open-two-new-canna-cabana-stores-in-ontario-302396395.html

50 dma now down to .32 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross. *Note that this is the 19th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is flat at $2.50, and the price closed below it for the first time on 2/27/25.
VWAP 2.31 US, Down today
Close $2.30 US, Down today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 2/25/25: High Tide is pausing the Purecan deal.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line around $2.40, below the 200 dma. Political uncertainty is a downer. Time will tell...

50 dma now down to .34 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross. *Note that this is the 18th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is up to $2.50, and the price closed below it for the first time on 2/27/25.
VWAP 2.39 US, Down today
Close $2.42 US, uP today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 2/25/25: High Tide is pausing the Purecan deal.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line around $2.40, below the 200 dma. Political uncertainty is a downer. Time will tell...

50 dma now down to .36 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross. *Note that this is the 17th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.40 US, Down today
Close $2.36 US, Down today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 2/25/25: High Tide is pausing the Purecan deal.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line below the 200 dma. Political uncertainty is a downer. Time will tell...

50 dma now down to .37 above the 200 dma, the previous several days of price dip consolidation still confirming the integrity of the Golden Cross. *Note that this is the 16th day in a row since the October Golden Cross that the 50 dma has gone down.* The 200 dma is flat at $2.49, and the price closed below it for the first time on 2/27/25.
VWAP 2.42 US, uP today
Close $2.47 US, uP today.
Volume was less than the 10-day average volume today.
$3 US VWAP close on 10/29/24.
Above $3 US VWAP close on 11/29/24.
Below $3 US VWAP close on 12/30/24
$2.71 US VWAP close on 1/30/25
$2.54 US VWAP close on 2/28/25/
News on 2/25/25: High Tide is pausing the Purecan deal.
Another leg up coming? Maybe, but certainly still a low buying opportunity for some as the stock consolidates & finds a new support line below the 200 dma. Political uncertainty is a downer. Time will tell...